Albany College of Pharmacy and Health Sciences President's Report

ALBANY COLLEGE OF PHARMACY A N D H E A LT H SCIENCES PRESIDENT’S REPORT AC P H S P RE SID E N T’ S RE PO RT 3

BEYOND

PRACTICE G R E G D E W E Y, P H . D .

PRESIDENT

READY

SHORTLY INTO MY FIRST YEAR AS PRESIDENT OF the College, I had a conversation with Larry Doud, the CEO of Rochester Drug Cooperative. I asked Larry about the qualities he looks for in new graduates. He said, “I want them to be practice ready. They need to hit the ground running and be able to solve practical, everyday problems.”

I have thought a lot since then about what it means to be practice ready and have had numerous conversations with faculty, alumni, and preceptors about this subject.

Educating students to be practice ready is always a challenge for a professional school, particularly one focused on pharmacy and the health sciences. There is always conflict about which new subjects to include and which ones to leave out.

That is especially true today when our knowledge of human biology and the very practice of health care are changing at unprecedented rates.

While being practice ready is clearly important, we need to strive for something even better. To enjoy success across an entire career, you must be able to anticipate, and adapt to, the shifting demands of your profession. In other words, you need to go Beyond Practice Ready.

creating our two student operated pharmacies in medically underserved areas of the Capital Region. The first pharmacy – which opened in March – is located in the Hometown Health Centers clinic in Schenectady. The second pharmacy will open in Albany later this year.

These pharmacies are not traditional community pharmacies.

They are linked directly to clinics thereby allowing delivery of a wider range of health care services. Being situated in medically underserved areas provides the added benefit of helping serve our communities while exploring a broader scope of health care practice.

These pharmacies will provide students from across all of our programs with a range of entrepreneurial and health care related learning experiences and opportunities. These may include learning how to run a business, the proper way to conduct point of care testing, or learning to counsel and educate community members – just to name a few.

Regardless of their field of study, the students involved in these pharmacies will gain experience that goes beyond the classroom and will benefit them throughout their lives.

Beyond Practice Ready is the name of our current fundraising campaign, but it is not simply a campaign title or marketing slogan. It is a philosophy that we are integrating across all areas and functions of the College, and the Campaign is one of the ways we are working to support those efforts.

Though we are just now formalizing the rollout of our Beyond Practice Ready initiatives, there has been a long line of individuals from ACPHS who have exemplified this approach.

We have selected six of these alumni, faculty, and staff to feature in this magazine to illustrate how the Beyond Practice Ready attitude can pave the way for a lifetime of sustained success.

To go beyond practice ready is not so much learning a new set of subjects as it is about developing an attitude. It is about being resourceful, adaptable, inventive, and even a little entrepreneurial.

No one knows what the future holds, but one thing is certain – change is coming. Going Beyond Practice Ready will allow ACPHS graduates to become future leaders of health care.

But how do you teach this attitude? How does someone learn these characteristics? Pharmacy education has always had a strong experiential component and pharmacy practice experiences can be transformative. That is the motivation behind

4 AC PHS

PR ESI D E N T ’S RE PORT

AC P H S P RE SID E N T’ S REPO RT 1

THE

S T R AT E G

AG

2 AC PHS

PR ESI D E N T ’S RE PORT

A STRATEGIC PLAN IS, ABOVE ALL ELSE, A PLAN. Like all plans, it guides one’s thinking, but more often than not, it needs to be adjusted in response to a fluid and dynamic world.

Over the past two years, the ACPHS community has worked together to create a Strategic Agenda derived from our Strategic Plan (which was completed in 2012).

The goal of the Strategic Agenda is not to replace the existing Strategic Plan but rather to articulate the original vision in a context that sets priorities and specific metrics.

Since launching this initiative, we have held two Campus retreats, several town hall meetings, and established focus groups for each of the five imperatives of the Strategic Agenda.

This community-wide effort has involved faculty, students, academic administration, and professional staff.

Not surprisingly, some aspects of the Strategic Agenda’s implementation have moved faster than others. As you will read, tangible progress has been made in several key areas while other areas present more complex challenges that are not as easily resolved.

Despite the varying degrees of progress to date, our efforts continue to be guided by one unifying principle – to create the best academic experience possible for ACHPS students.

IC

ENDA AC P H S P RE SID E N T’ S RE PO RT 3

O N T H E F O L L O W I N G T W O PA G E S A R E T H E F I V E I N I T I AT I V E S T H AT C O M P R I S E T H E AC P H S S T R AT E G I C AG E N DA A LO N G W I T H U P DAT E S O N T H E P R O G R E S S T H AT H A S B E E N M A D E I N E AC H A R E A .

1. PHARMD+ OBJECTIVE: The expansion of pharmacy schools across the country has resulted in a more competitive landscape, not only for attracting students, but also for our graduates gaining employment. We must explore curricular, pedagogical, and programmatic approaches to enhance the competitiveness of our students in the workplace and to make our program stand out from others. In short, we need to define the “+” in PharmD+.

UPDATE: A key point of emphasis in the PharmD+ initiative is to adjust the core pharmacy curriculum to provide students with greater flexibility to focus on specific career paths within pharmacy.

One of the areas being explored is the bundling of designated professional electives to create pathways leading to certificates.

The coupling of a certificate and a Pharm.D. degree will provide students with a level of expertise beyond the “standard” Doctor of Pharmacy, thereby creating a point of differentiation for ACPHS students when competing with graduates from other schools.

The Vermont Campus will refine this approach further by developing new courses focusing on primary care and working with the medically underserved. This curricular focus will provide graduates who choose the primary care option with the ability to more quickly transition into settings such as physician offices and ambulatory care clinics while at the same time helping meet the expanding need for primary care services.

As part of this initiative, the College’s Vermont Campus is also piloting a longitudinal community pharmacy Introductory Pharmacy Practice Experience (IPPE) with a small cohort of students. Instead of the IPPE taking place in the summer as it does now, the College is considering offering the IPPE during the spring semester so that students can better connect their classroom work and their practice experiences. Based on the positive feedback from the first group of students to test this model, a decision has been made to expand the program for the 2016-17 academic year.

for our graduates. To be a sustainable, vibrant institution, we need at least two large undergraduate degree programs (with 100 students or more) and one large graduate program (50 students or more). These programs need to be aligned with our core strengths and the pharmacy program. Our conversation will define the best prospects for programmatic enhancement and growth.

UPDATE: In spring 2016, the College announced that it would be adding a B.S. program in Public Health, offering a strong complement to the current program mix focused on human health and health care. Students will be eligible to enroll in the Public Health program beginning in fall 2016.

In conjunction with the introduction of the B.S. in Public Health, a new Department of Population Health Sciences was created as part of a strategic realignment for the College. The new department will house the B.S. in Public Health and the existing M.S. in Health Outcomes Research, a pairing that links two programs with natural synergies and strong potential for growth.

In addition to these efforts, ACPHS is developing online certificate programs targeting emerging skill sets being sought by employers in the current health care and research environment.

Proposed disciplines for graduate certificate programs include Nanomedicine, Pharmacovigilance (Drug Monitoring and Safety), Regulatory Science/Affairs, and Economics of Healthcare. The first certificate courses are expected to be offered beginning in the 2016-17 academic year.

Plans include the ability for individuals to pursue a single certificate program or combine multiple certificates to earn a master’s degree.

The College’s two student operated pharmacies (see page 7) will offer additional integrated learning opportunities – ranging from counseling patients to running a business. These experiences will not only enhance a student’s education, but it will provide them with benefits that will extend throughout their careers.

3. CENTERS OF EXCELLENCE OBJECTIVE: Centers of Excellence provide a focus for faculty scholarship, research, and pedagogical innovation. They also provide a focus for fundraising opportunities. A Center of Excellence will consist of a cluster of faculty working on a common overarching problem. Centers can house endowed chairs, professorships, lecture series, core facilities, grant opportunities, and student research opportunities. Centers will foster interactions that allow faculty and students to work in interdisciplinary collaborative teams. Our strategic conversation has explored the themes and sustainable models for these Centers.

2. ENHANCING ACADEMIC PROGRAMS, EXISTING AND NEW OBJECTIVE: We need to think strategically about which programs in addition to pharmacy we want to emphasize, i.e., which ones will attract students and provide the greatest opportunities

UPDATE: The most efficient and effective way to establish Centers of Excellence at a small college is to build out from existing areas of strength. In 2015, the College asked faculty and staff to submit ideas that had the potential to become Centers of Excellence.

4 AC PHS

PR ESI D E N T ’S RE PORT

Following review of the proposals, two Centers of Excellence concepts have been selected for development. One proposal is focused on Epigenetic Studies; the second proposal centers around Anti-Microbial Drug Resistance. Each of these disciplines includes an existing foundation of ACPHS faculty experts with demonstrated research achievements in the field.

The College next plans to bring in an external consultant to work with the groups to refine the mission and operation of each Center. The groups have also submitted a “fundraising” whitepaper that articulates to a non-scientific external audience the vision and need for their Center.

These activities are viewed as developmental steps that will eventually lead to the launch of two Centers of Excellence, and ultimately, a stronger research environment at ACPHS. 4. THE STUDENT EXPERIENCE OBJECTIVE: We need to continue our work on developing a vibrant campus community. We need to build activities that create a strong interface between academic affairs and student affairs. Co-curricular and extra-curricular activities must link what happens in the classroom with what happens outside the classroom, providing a holistic student experience. Our conversation will explore how we can build this type of experience and how we can enhance our campus life. We will explore the human, physical, and technological infrastructure requirements to develop such a student experience.

UPDATE: To create the best possible experience for its students, a College must offer a complementary mix of academic and non-academic programming. Advising and mentoring play key roles in helping ensure the ideal balance is achieved for each student.

During the 2015-16 academic year, the College began offering new monthly training sessions for faculty advisors to help refine their counseling and advising skills. In parallel with this effort, a “Coffee Talk” series was launched for first year students.

These informal discussions provide a relaxed setting for students to discuss anything on their mind with a member of the Student Affairs staff.

In the area of mentoring, one new program was kicked off and another one expanded. A new initiative launched in response to student feedback uses the LinkedIn platform to connect students with alumni. The initial feedback from both students and alumni on this effort has been very positive. Additionally, the College’s renewed effort to increase the number of peer mentors on campus resulted in 140 applications for 89 positions.

The response allowed every student seeking an upperclass student mentor to be matched with one, including all students on the Vermont Campus.

Looking ahead, the College will be pursuing a prestigious Community Engagement Classification from The Carnegie Foundation. To receive this designation, institutions must demonstrate, among other things, how they “prepare educated, engaged citizens; address critical societal issues; and contribute to the public good.”

5. CORPORATE RELATIONS AND THE TEACHER-CONSULTANT MODEL OBJECTIVE: ACPHS has had strong historical ties to various sectors of pharmacy and the pharmaceutical industry. We need to institutionalize these ties in more formal ways and provide greater experiential learning access to industry for our students. Our practices involving rotations, internships, fellowships, and residencies need to be aligned. Strategic partnerships with specific organizations and corporations need to be developed in an intentional manner. As these partnerships grow, there will be opportunities for faculty and student consulting projects, and we need to build the business development infrastructure to support this activity. Our strategic conversation will center on how we build these corporate relations and the sectors on which we will focus.

UPDATE: Three key initiatives have been identified as vehicles for building and enhancing the College’s ties with businesses and corporations: (1) Fellowships/residencies/internships that split between ACPHS and the corporate partner, (2) ACPHS educational programs or certificate offerings (in-person and online) for employees at these institutions and organizations, (3) Business consulting services that would be performed by students under the guidance of ACPHS faculty and staff.

Following the establishment of these three areas of focus, a follow-up survey was sent out to faculty and staff at the College.

More than 50 individuals responded that they would be interested in participating in one or more of these initiatives, with each identifying specific areas of interest and strength.

We have decided to first target corporations that are local to our campuses and those which we have pre-existing relationships.

Five companies have been identified as potential partners for one of the above mentioned initiatives.

Feedback from these initial outreach efforts will be used to further refine the College’s corporate relations strategy as we explore additional partners and opportunities.

AC P H S P RE SID E N T’ S RE PO RT 5

T H E FAC E OF NEIGHBORHOOD

H E A LT H C A R E 6 AC PHS

PR ESI D E N T ’S RE PORT

T H E C O L L E G E ’ S T WO S T U D E N T O P E R AT E D PHARMACIES WILL PROVIDE DISTINCT LEARNING OPPORTUNITIES FOR STUDENTS WHILE PROVIDING MUCH NEEDED SERVICES TO LOCAL COMMUNITIES.

ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES announced plans in 2015 to launch two not-for-profit community pharmacies in medically underserved areas of the Capital Region. The first pharmacy - College Hometown Pharmacy opened in March 2016 in the Hometown Health Centers clinic in Schenectady, NY. The second pharmacy, College Parkside Pharmacy, will open in summer/fall 2016 in the South End of Albany.

Each pharmacy will offer the dual benefit of (1) providing a distinctive and innovative experience for ACPHS students and (2) improving access to pharmacy and health care services for members of the local community.

MEETING AN EDUCATIONAL NEED The pharmacies will allow student pharmacists to develop and refine their advanced practice skills. As full-service pharmacies, they will include point of care screening services coupled with associated disease state counseling.

Under the supervision of a licensed pharmacist, students will have opportunities to expand their patient counseling skills in areas that may include: Anticoagulation Management Medicare Part D Plan Finder n Blood Pressure Screening n Disease Management and Prevention n Medication Therapy Management n Cholesterol Screening n Self Care n Osteoporosis Screening n Immunization Therapy n Wellness Counseling n n

In addition to the clinical skills needed to be a successful pharmacist, students will learn the essential business skills required to successfully manage a pharmacy. The ACPHS pharmacies will provide hands on experience in revenue analysis, inventory turnover analysis, break-even analysis, and pharmacy cash-flow analysis. Through their experiences in the pharmacies, students will be better prepared to “think like entrepreneurs,” proactively seeking out opportunities not only for operational efficiencies and growth but for creative health care business models.

The additional time spent working with real patients in real clinical settings combined with the managerial, problem solving skills required to run a pharmacy will ensure ACPHS students are Beyond Practice Ready when they graduate.

MEETING A COMMUNITY NEED The unfortunate truth is that the nation’s lower income communities do not attract as many retailers and providers of services as more affluent areas. Pharmacy is no exception. Medical and public health services also lag in these areas.

A study in the November 2014 issue of Health Affairs found that from 2000-2012 the number of pharmacies in predominantly Hispanic and black communities of Chicago declined by 17% and 11% respectively. Over that same period, the number of pharmacies in Chicago’s white communities increased by 30%.

According to the study’s authors, the exodus of pharmacies from underserved areas has led to the creation of “pharmacy deserts.”

Furthermore, the National Center for Health Statistics reports that in 2013, 8.4% of primary care physicians would not accept new patients. The acceptance of Medicaid patients is even more severe with 35% of physicians not taking new Medicaid patients.

Lower income areas with predominantly Medicaid populations are clearly not getting the primary care services they need.

MEETING FUTURE NEEDS In addition to dispensing medications and providing related services, each pharmacy will serve as a “collaboratory” where the College will partner with local health care providers to jointly offer an expanded range of clinical services. The pharmacies will be “convenient care” centers much like commercial retail clinics, but will offer a broader range of services associated with patient wellness.

The ability to share space with a physician or nurse practitioner, for example, will ensure patients have convenient access to multiple levels of health care. It will also help prepare students to serve as part of a health care team, one of the core tenets of a patient-centric approach to care.

Plans for the student operated pharmacies include space where students will be able to host educational forums about certain health topics or disease states, thereby expanding the learning experience to include a component of public health.

The ACPHS student operated pharmacies will serve as prototypes for health care in disadvantaged areas of the Capital Region. They will avoid the expansion of pharmacy deserts by allowing for improved access to prescription medications and preventive health care services in medically underserved areas.

Over time, the College envisions the pharmacies emerging as the “face of neighborhood health care.”

AC P H S P RE SID E N T’ S RE PO RT 7

ONE

STEP

AHEAD 8 AC PHS

PR ESI D E N T ’S RE PORT

D

BY CONTINUING TO CHALLENGE S E N I O R A S S O C I AT E D E A N H A S H E L P E D R E D E F I N E W H AT I T TO BE A

ROB DICENZO, PHARM.D., BCPS, FCCP, EMBODIED the attitude of Beyond Practice Ready long before the term was coined by ACPHS President Greg Dewey.

The Senior Associate Dean of Academic Affairs and Operations – who was promoted to the newly created position at the start of the 2015-16 academic year – has consistently worked throughout his career to keep pace, and stay one step ahead of, the changes in his profession.

After years of working as a clinical pharmacist at Rochester General Hospital, Dr. DiCenzo decided to expand his clinical skills and practice opportunities by pursuing his Doctor of Pharmacy at Albany College of Pharmacy and Health Sciences. Remember, this was a time when the Pharm.D. was an advanced degree, not the minimum requirement that it is today for entry level pharmacists.

As he was finishing up his Pharm.D., Dr. DiCenzo received an offer from the University at Buffalo (where he received his bachelor’s degree) to complete a two year fellowship in Antiretroviral Pharmacology and Pharmacometrics. “The opportunity wasn’t something I had planned for, but I figured it could only help me,” says Dr. DiCenzo. And it did.

The fellowship became a springboard for his entrée into academia.

He received an academic appointment as an Assistant Professor at the University at Buffalo in 2000 and began developing a research program in the Infectious Disease Division of the Department of Medicine at the University of Rochester Medical Center.

It was an historic time in the practice of medicine and pharmacy as researchers were beginning to harness the power of combination therapies in treating HIV/AIDS patients.

Dr. DiCenzo explains, “We now had these good therapies, but we still needed to understand how best to dose patients in order to increase adherence, decrease adverse events, and optimize individual patient outcomes. This was particularly difficult when patients had handfuls of pills to take each day. A lot of the research that I did centered around optimizing these patients’ medication regimens.”

In 2008, he left his position as Associate Professor at the University at Buffalo to join the founding team at the St. John

H I M S E L F, ROB DICENZO MEANS P H A R M A C I S T.

Fisher College Wegmans School of Pharmacy as the Director of Experiential Education. He was at the school for three years before being named Chair of the Department of Pharmacy Practice at ACPHS. Without necessarily planning it, his range of previous experiences – clinical pharmacist, fellow, educator, administrator, researcher – had coalesced to provide him with the ideal background for the Chair position. You might say he was Beyond Practice Ready.

Dr. DiCenzo arrived at ACPHS in 2010 during a transitional time for the College, and in particular, the Department of Pharmacy Practice. The department had not had a permanent leader for nearly a decade, and there was now a second Department of Pharmacy Practice on the Vermont Campus which was headed by its own chair.

“My focus at that time was to provide stability for the department while working to facilitate better integration between the two campuses,” he says. “Working with Dean Angela Dominelli, we rolled out a plan to merge the two departments into a single unit during the 2012-13 academic year.”

Fast forward to today and the two departments have been successfully combined, with Vermont now benefitting from a dedicated Vice Chair position. Dr. DiCenzo, however, continues to look ahead.

In his new role, he will be focused on the mission and goals of both the School of Pharmacy and Pharmaceutical Sciences and the College. Initiatives will include helping define and implement the PharmD+ initiative (see page 4); working closely with faculty to incorporate the new active learning classrooms into the curriculum; and identifying opportunities to integrate the student operated pharmacies into coursework, practice experiences, and other curricular and co-curricular activities.

And if that’s not enough, this spring Dr. DiCenzo began a two year term as President of APhA’s Academy of Pharmaceutical Research and Sciences which includes a place on their Board of Trustees. He acknowledges it will be a demanding role, but he is motivated by the opportunity to “keep on the cutting edge of what’s happening in our profession.” After all, it’s something he’s been doing his whole career.

AC P H S P RE SID E N T’ S RE PO RT 9

S TA N D I N G U P F O R

STUDENTS

10 AC PHS

PR ESI D E N T ’S RE PORT

NEW DEAN OF STUDENTS WENDY NEIFELD WHEELER DRAWS UPON HER DIVERSE BACKGROUND TO PROVIDE ACPHS S T U D E N T S W I T H G U I D A N C E A N D S U P P O R T.

WALK INTO WENDY NEIFELD WHEELER’S OFFICE any time of day, and one thing will strike you immediately.

She’s standing.

She uses a standing desk to help keep her back healthy, but it provides an appropriate metaphor for her position as Dean of Students. She can be counted on to stand up for the needs and interests of each student at the College.

Advocating for students is nothing new for Dr. Neifeld Wheeler, but doing it at ACPHS is a change. Prior to joining the College last summer, she had spent the previous 29 years at the College of St. Rose.

Her roles there included: Director of Residence Life, Assistant Director of Counseling and Psychological Services, Coordinator of the Risk Assessment and Alcohol Awareness Project, Chief Judicial Officer, and Director of Parent and Family Relations.

She readily admits that the St. Rose community was like family, and while she had occasionally explored other opportunities through the years, it was a place that felt like home.

Despite her known feelings for St. Rose, she was contacted by a former colleague last spring to see if she would be interested in the Dean of Students opening at ACPHS. “I thought, ‘I’ll take a look,’” she says. “But the more I learned, the more I realized that this was really an incredible opportunity. It had so many pieces of the work that I had done before and other things I was interested in doing.”

She decided to formally apply for the position, and each step along the way she became more excited about joining ACPHS. “Every time I met with a person from the College, visited the campus, or communicated with someone from the search committee, I felt a tug. It was a feeling that ‘you can do more than just fit in here, you can make a contribution.’”

Near the end of the interview process, Dr. Neifeld Wheeler gave a presentation in which all members of the ACPHS community

were invited to attend. A young female student approached her following the presentation and explained that she had attended each of the candidates’ talks and that Dr. Neifeld Wheeler’s stood out from them all. She added, “You can make a difference here.”

It was a powerful moment for Dr. Neifeld Wheeler who now meets regularly with the young woman to discuss issues related to the College and beyond. “I was taken aback with her words, her thoughtfulness, and her courageousness. I came home that day and told my husband that it didn’t matter whether or not I was offered the position. The fact that this student made it a point to tell me what she did – that was more important to me than the ultimate outcome.”

Clearly, this student was not the only one impressed by Dr. Neifeld Wheeler. She was offered the position, accepted, and began on July 1, 2015.

In less than a year, Dr. Neifeld Wheeler has quickly embraced the Beyond Practice Ready approach. One of her top priorities is to encourage students to reach out to members of the local community in new and different ways. This community engagement philosophy will involve broadening education and programming surrounding LGBT needs, homelessness, and other social issues. In Dr. Neifeld Wheeler’s words, “We want to prepare our students for working with more disenfranchised clients” – an effort that aligns well with one of the core objectives of the student operated pharmacies.

She will also be leading the charge for the College to obtain the Carnegie Foundation’s Community Engagement Classification.

This prestigious designation is awarded to schools with an institutional focus on community engagement.

As she reflects back today on her decision to join ACPHS, she says, “You have an innate, gut feeling when a place is the right fit. You may or may not be able to pinpoint a specific moment of realization, but you will know. I’ve lucked out with a Capital L.” So has the College.

AC P H S P RE SID E N T’ S RE P O RT 11

INDUSTRIAL

EVOLUTION

12 AC PHS

PR ESI D E N T ’S RE PORT

AS A POSTDOCTORAL FELLOW AT B R I S T O L- M Y E R S S Q U I B B , DEREK PETERSON ’15 IS BUILDING T H E F O U N DAT I O N F O R A C A R E E R I N T H E P H A R M A C E U T I C A L I N D U S T R Y.

DEREK PETERSON’S GOAL HAD ALWAYS BEEN TO work in the pharmaceutical industry as a Medical Science Liaison. He pursued the Pharm.D. degree on the ACPHSVermont Campus (graduating in 2015) because he knew it would prepare him well for such a role.

For those unfamiliar with the position, a Medical Science Liaison (MSL) meets regularly with physicians, helping ensure products are being used effectively and serving as a resource for scientific related questions and information.

To help further prepare himself (and other classmates) for a career in industry, Dr. Peterson started a student chapter of the Industry Pharmacists Organization near the end of his third professional year. Despite the fact that he would soon be heading out on his fourth year rotations, Dr. Peterson still played an active role in the group’s first year activities, making presentations and arranging for guest speakers.

Everything was proceeding according to plan until his final year as a pharmacy student when a rotation at the headquarters of Amgen set him on a different path. “You tend to work alone as an MSL, and I realized at Amgen how much I liked working in a team environment,” he says. “I also saw the benefit of being involved with the planning and brand strategy that takes place in-house, and how valuable it is to have that experience before heading out into the field as an MSL.” Following the Amgen rotation, Dr. Peterson reset his sights from a field-based industry fellowship to one focused on in-house functions. He applied to the Rutgers Pharmaceutical Industry Fellowship program – the biggest (and most competitive) program of its kind for the pharmaceutical industry – and was accepted into the two-year program. He is now a Postdoctoral Fellow at Bristol-Myers Squibb (BMS) in Princeton, New Jersey.

There are approximately 120 fellows at nearly 20 different pharmaceutical companies in the Rutgers program, and in addition to their day-to-day responsibilities, the group meets every two weeks to participate in a Professional Development Series. Much as he did at ACPHS, Dr. Peterson has taken an active role with this group, serving as co-chair of the Series’ committee, where he helps choose discussion topics for each meeting, plan the content, and recruit guest speakers.

During his first year at BMS, he is working in the Immunoscience therapeutic area, helping support Orencia, a drug for rheumatoid

arthritis. He will spend six months apiece with the Medical Information and Medical Strategy teams.

As part of the Medical Information team, he will split his time between responding to “medical information requests” (inquiries from health care practitioners) and “promotional review,” which focuses on customer-facing communications.

“When you are able to watch something go from concept generation to the customer’s hands, you develop an appreciation for how scrutinized the process is. I knew it was an extremely regulated industry, but I had no idea how much effort goes into making sure information is transparent and balanced.”

In Medical Strategy, he will work with colleagues to determine the various medical meetings the Orencia team will attend in 2016, and more specifically, what they will be discussing and presenting at these meetings. He will also do competitive research, assessing new medications coming to market and determining if/how they will compete with BMS products.

Dr. Peterson will transition to a new therapeutic area in July 2016 – Immuno-Oncology Publication Strategy – where he will focus on high impact journals, helping manage the publications for a specific product in the BMS portfolio.

He was also recently selected for the honor of serving as one of two Co-Chiefs for the entire fellowship program. In this multi-faceted leadership role, his responsibilities will include promoting and encouraging the growth of each of the 160 fellows in next year’s program.

It’s a lot to manage, but he is often reminded of why he does it all. “We have patients who come to our Professional Development Series, and you listen to their stories,” he says.

“It almost brings tears to your eyes when you hear how they have benefitted from these products. It reminds you why you are coming to work every day. It’s all about the patients.”

Dr. Peterson hasn’t closed the door on becoming an MSL one day, but for now, he’s focused on completing his fellowship and seeing what type of in-house opportunities are available to him in industry. Regardless of what he decides to do, there’s no question that he will be Beyond Practice Ready when he begins the next phase of his career.

AC P H S P RE SID E N T’ S RE PO RT 13

THE

TOP ONE

PERCENT

14 AC PHS

PR ESI D E N T ’S RE PORT

A S S O C I AT E P R O F E S S O R K A R E N G L A S S ’ S RECENT NIH GRANT SUBMISSION RECEIVED THE HIGHEST ACHIEVABLE SCORE, BUT THE BIGGER S T O R Y M AY B E T H E I M PA C T O F H E R R E S E A R C H .

THE LAST TIME KAREN GLASS, PH.D., WAS PROFILED in the President’s Report, the Associate Professor on the Vermont Campus had just received her first research grant from the National Institutes of Health (NIH).

The findings generated over the following three years demonstrated more than enough promise for her to receive continued funding. Yet, despite the quality of her research and potential impact of the work on a variety of disease states, there were no guarantees when she began working on the follow-up grant submission in 2015.

The score speaks volumes for the quality of Dr. Glass’ research, but it also reflects the importance of the work she is doing. The focus of her efforts centers on bromodomains which are small protein modules contained within larger protein structures.

Scientists have identified approximately 60 human bromodomains and organized them into eight families.

Bromodomains play a critical role in the body by influencing the expression of genes in our cells. These interactions drive a range of biological processes, including in some cases, the onset or advancement of disease.

Consider that between 2005-2014, the overall budget for the National Institutes of Health decreased by nearly 20% after adjusting for inflation. The competition for NIH research dollars is more intense than perhaps at any time in the Institute’s history, meaning there are excellent investigators working on some of our most pressing health threats who are unable to obtain federal funding.

Scientists have long understood the influence and importance of bromodomains, but until recently, they were largely thought to be inaccessible as drug targets. In 2010, however, two separate labs demonstrated that small molecules could be developed to inhibit the actions of bromodomains. These findings have fueled great interest in bromodomains as potential new drug targets for preventing or reducing the risk of disease.

At times like this, it pays to be Beyond Practice Ready.

Each of the 60 bromodomains has been identified and mapped, but researchers still do not know a lot about their biological function. Dr. Glass’ first grant focused on a single bromodomain in Family IV named BRPF1.

Dr. Glass’ most recent submission was bolstered by six peerreviewed publications based on her research from the original grant, an above-average number of journal articles for this type of grant, which is categorized by NIH as an R15.

She has also worked to cultivate a network of collaborators at institutions that include the University of Vermont (where she earned her Ph.D.), the University of Texas MD Anderson Cancer Center, and England’s Newcastle University. “Science today really has to be a team effort because the reality is that no lab can do everything,” says Dr. Glass. “You can make a more complete story by working together.”

Her accumulated credentials, combined with the encouraging results of her initial research findings, gave Dr. Glass reason to be optimistic about being awarded a second grant.

But in the current funding environment, nothing can be taken for granted.

So when Dr. Glass received approval from NIH on a three-year grant totaling $384,000 it was an impressive accomplishment.

But it was made even more noteworthy when she learned that her submission had earned a score of 10. Ten is the highest score one can receive for an NIH grant submission, an achievement that ranks Dr. Glass in the top 1% of all grant applications that NIH scores.

In the new grant, Dr. Glass will study all seven bromodomains in Family IV. The focus of these efforts will be to determine whether there is a consistent method for how the bromodomains in Family IV function.

“While bromodomains offer great promise as potential drug targets, it is difficult to move forward with the development of new drugs until we better understand the biological function of each bromodomain,” said Dr. Glass. “Once, however, we are able to better document how bromodomains work, our ability to develop next generation drugs targeting cancer and other diseases will improve significantly.”

The research success of Dr. Glass is also good news for ACPHS students, several of whom assist her in the lab. “Pharmacy students have a great background for research as a result of coursework in disciplines such as math, physics, and chemistry,” she says. “I’m impressed by how quickly they hit the ground running once they begin working in the lab.”

This ability to draw upon their education, adapt to new situations, and contribute to a team will no doubt serve these graduates well throughout their careers – just as it has for Dr. Glass.

AC P H S P RE SID E N T’ S RE P O RT 15

ILL

C O M M U N I C AT I O N 16 AC PHS

PR ESI D E N T ’S RE PORT

A S S O C I AT E P R O F E S S O R PAU L D E N V I R B E L I E V E S T H AT E F F E C T I V E P R O V I D E R - PAT I E N T C O M M U N I C AT I O N I S K E Y T O I M P R O V I N G H E A LT H O U T C O M E S .

PAUL DENVIR, PH.D., ARRIVED AT ACPHS SIX YEARS AGO admittedly feeling a bit out of place. Without the benefit of a group of like-minded peers, the communication scholar began talking with clinical faculty at the College about potential collaborations, and in the process, he found a new focus for his research. Today, Dr. Denvir is applying his interest in provider-patient interaction to a different and understudied type of provider – the pharmacist.

If you look at the arc of Dr. Denvir’s career, it might appear he arrived at this point after following a precise plan, but he readily admits that was never the case. “I believe a lot of life is capitalizing on serendipitous opportunity. Being attuned to what is available to you. Explore. Taste. Try. I try to tell this to students all the time.”

An advanced degree was never even on his radar until a faculty member suggested he consider graduate school while he was a senior at the College of St. Rose. He decided to continue his education at the University at Albany where he received a master’s degree in Interpersonal and Intercultural Communication and then eventually a Ph.D. in Sociology (with a concentration in Health Communication).

While at UAlbany, he began working closely with Dr. Anita Pomerantz, one of the foremost authorities in the field of Conversation Analysis. This emerging field closely examines the details and dynamics of social interaction, emphasizing the significance of word choices, intonation patterns, and nonverbal cues in communication outcomes.

“At the time I was in school, there were a lot of people who were using Conversation Analysis to ‘improve the toolbox.’ I was more interested in using the tools to address problems instead of making more tools. That was a big turn for me professionally, and I’ve really embraced that approach here at ACPHS,” he explains.

Working with both students and faculty members such as Drs. Jeffrey Brewer and Katie Cardone of the Department of Pharmacy Practice, Dr. Denvir has been recently studying the communication skills required to successfully engage patients in Medication Therapy Management (MTM).

From a communication perspective, there are three parts to an MTM consultation. The first, and often most difficult phase, is persuading the patient to participate in a medication review. Once the patient agrees to an MTM consultation, the pharmacist has to successfully elicit information about their symptoms, medication usage, lifestyle, and other factors that may impact their health and wellness. Lastly and most importantly, the pharmacist must help the patient understand the critical importance of adherence in any future medication regimen.

“For me, adherence is the heart of matter,” he says. “If the patient struggles with adherence, then all of the quality work that leads up to this point goes out the window. My training gives me a way to assess provider-patient communication and produce recommendations on how to improve these engagements.”

Dr. Denvir will also play a key role in the College’s new Bachelor’s in Public Health program which evolved from the former B.S. in Health and Human Sciences. The new program will increase the emphasis on the social and behavioral aspects of public health, including elements of health outcomes research and data analytics. The program faculty have been using the phrase “scientifically grounded, socially engaged” as a compass point for the new direction.

He believes the Public Health program will appeal to a wider range of students. “I talk with many prospective students who have a strong sense of altruism and would like to direct those interests into patient care, but who may be uncomfortable with the one-to-one dynamic. I tell them to start thinking about a community or a population as their patient. That’s when they see another avenue open up to them.”

The term Beyond Practice Ready means different things for different people. For Dr. Denvir, it means helping students develop outstanding patient communication skills, not just outstanding clinical care skills. “Communication is not some ideal overlay that you add on. It’s a skill set, and it’s every bit as important as your ability to order and interpret the results of a test.”

AC P H S P RE SID E N T’ S RE P O RT 17

CLINICAL

STUDY

18 AC PHS

PR ESI D E N T ’S RE PORT

N A B E E L A A H M E D ’ 1 5 I S P U R S U I N G A T W O -Y E A R R E S I D E N CY AT N Y U L A N G O N E M E D I C A L C E N T E R WITH THE GOAL OF BECOMING AN I N F E C T I O U S D I S E A S E S C L I N I C A L P H A R M A C I S T.

NABEELA AHMED, PHARM.D., STILL RECALLS THE name of the young woman who hosted her Admissions tour at ACPHS. “Her name was Tasmina. I remember her being very motivated and excited to begin her career as a pharmacist. Her enthusiasm really captured me.”

At the time, Dr. Ahmed was like many high school students who tend to think of pharmacy as something practiced only in a community setting. It wasn’t until her entrance into the professional program that she began to learn about the range of opportunities available to pharmacists.

“I was not aware of the field of clinical pharmacy until my P1 year,” the Class of 2015 graduate admits. “As I began to talk with clinical faculty members at the College and learned more about this area, something clicked for me. I suddenly knew that this was what I wanted to do.”

She quickly recognized that most of the clinical faculty at the College were residency-trained. If this was an area that she intended to pursue, she knew that she would need to begin taking steps to prepare herself for a pharmacy residency.

That’s when fate intervened.

Dr. Ahmed saw a posting on a College bulletin board that Samaritan Hospital in Troy was looking for pharmacy interns.

She applied during her P2 year and was selected for an internship working 16-20 hours per week at the hospital. She was able to work side-by-side with the hospital’s two clinical pharmacists (both of whom were residency-trained), and the experience helped cement her career direction.

She also took advantage of opportunities to expand her skill set by joining professional organizations on campus. She was an active member of the Student Society of Health-system Pharmacists (SSHP), as well as the student chapters of the American College of Clinical Pharmacy (ACCP) and the American Pharmacists Association (APhA-ASP).

Through her memberships in those organizations, Dr. Ahmed participated in activities and programs related to poison prevention, bone health, care screenings, brown bag reviews, and more. In addition to providing valuable services to the community, these

experiences also helped Dr. Ahmed refine her skills in areas such as public speaking, making presentations, networking, and working with patients.

As she was building this impressive C.V., she recognized that research was an area where she was lacking experience. So during her P2 year, she assisted in the lab of Associate Professor Nimish Patel, an infectious diseases (ID) pharmacist at the College.

All of these activities made for a busy schedule, but she loved what she was doing, and she was accumulating the types of experiences needed to make herself a strong applicant for a pharmacy residency.

Whether she realized it or not at the time, she was also taking steps to make herself Beyond Practice Ready. “To succeed as a resident, you must be well rounded in a variety of areas – patient care, didactic, research, administrative. I tried to get myself exposed to every aspect of the role before embarking on the process.”

When she learned that she had been selected for a residency at New York University Langone Medical Center, it was a dream come true for Dr. Ahmed, who grew up in the nearby borough of Queens.

“This residency is everything I expected and much more. You work hard. You have to be independent. And there is definitely a lot to balance,” she says. “But a residency has to be rigorous because it is only one year, and you have to be able to handle any situation that may arise.”

Nabeela’s long term goal is to become an ID clinical pharmacist.

She will take another step in that direction next year, as she recently accepted a position as the Postgraduate Year Two (PGY2) Infectious Diseases resident at NYU. Dr. Ahmed has worked hard to get where she is today, but she also credits the faculty at ACPHS as being instrumental to her success. “I was very fortunate to work with great faculty during my time as a student,” she says. “They told me what to do to stand out, and all of their recommendations were right on the mark. I credit their guidance and support with helping me achieve my goals.”

AC P H S P RE SID E N T’ S RE P O RT 19

F A C U LT Y P E R S P E C T I V E S BEYOND PRACTICE READY MEANS… “…

INSTEAD OF TRAINING

“ ...Students are not just prepared to practice, but prepared to excel in practice.”

K ATE CA B RA L , PHA RMACY PR ACTICE

“ …S TU DE N TS W I LL G R ADUAT E F RO M A P R O GR AM W I TH A S ET O F K N OW LED GE, AN D, O N C E I N THE WO R K F O R CE, THEY W IL L B E ABLE TO AD D TO TH IS B O DY O F K N OW L EDG E U S I NG T H E S K I L L S THAT T H E Y H AVE LEARNED.”

STUDENTS TO PRACTICE A PROFESSION, WE ARE EDUCATING THEM TO GO BEYOND: TO ENGAGE IN IT, TO ACCEPT CHALLENGES, TO IMPROVE IT, AND TO GROW INTELLECTUALLY.” LISA VINES , H U MANITIES AND COMMU NI CAT I ON

“ . ..S TUDE NTS POSSE SS INSIG HTS INTO T HE VALUE OF S EEKING , E VALUAT ING , AND INT E G R AT ING NE W KNOW L ED G E O R S KILLS AS PART OF T HE HE ALT H CAR E T E AM.” GINA GAR R IS ON, P H AR MACY PR AC T I C E

J EF F VO IGT P H A R M AC E UTICA L SCIEN CES

“ ...STUDENTS ARE PREPARED TO WORK IN THE REAL WORLD WITH REAL PEOPLE, GOING ABOVE AND BEYOND THE BASICS.”

“ … Our students have the skills to be self-directed, life-long learners who are both adaptable and innovative in their approaches to optimizing health outcomes in a changing environment.”

WEN DY PA RK ER, B ASIC A N D SO CI AL S CIENCES

“ … G R A D UAT E S A R E R E ADY TO FULLY PA RT I CI PATE I N T HE C HANGI NG H E A LT H CA R E D E L I VE RY S YST E M, A DAP T I N G TO A N E X PAND ED RO LE T H AT W I L L I M P R OVE T HE HE ALT H OF THE I R PATI E N TS.” B O B H AMILTON, P H AR MACY P R ACTICE

20 AC PHS

PR ESID E N T ’S RE PORT

SAR AH S CAR PACE, P H AR MACY PR AC T I C E

“ …A graduate of ACPHS is able to walk into a health care setting and, from day one, stand out as an actively engaged colleague, clinician, or scientist.”

ALLIS ON BU RTON-C HAS E BAS IC AND S OCIAL S C I E NC E S

S C H O L A R LY

ACTIVITY

REPORT JANUARY 1, 2015 – DECEMBER 31, 2015

AC P H S P RE SID E N T’ S RE P O RT 21

SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES D E PA R T M E N T O F P H A R M A C Y P R A C T I C E PUBLICATIONS P E E R R E V I E W ED A RTI C L E S Jeffrey Brewer Denvir P, Brewer J. “How dare you question what I use to treat this patient?”: Student pharmacists’ reflections on the challenges of communicating recommendations to physicians in interdisciplinary health care settings. Health Communication, 2014, 30(5):504-512, PMID: 24971910.

Katie Cardone Cardone K, Chen W, Grabe D, Batzold A, Manley H, Lodise TP. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis. Journal of Antimicrobial Chemotherapy, 2014, 69(7):1873-1876, PMID: 24722842.

Jo Carreno Werth B, Carreno J, Reveles K. Shifting trends in the incidence of Pseudomonas aeruginosa septicemia in hospitalized adults in the United States from 19962010. American Journal of Infection Control, 2015, 43(5):465-468, PMID: 25783865.

Carreno J, Kenney R, Bloome M, McDonnell J, Rodriguez J, Weinmann A et al. Evaluation of pharmacy generalists performing antimicrobial stewardship services.

American Journal of Health-System Pharmacy, 2015, 72(15):1298-1303, PMID: 26195656.

22 AC PHS

Jennifer Cerulli Cerulli C, Nichols-Hadeed C, Raimondi C, Stone J, Cerulli J. Facilitating intimate partner violence education among pharmacy students: What do future pharmacists want to know?

Currents in Pharmacy Teaching and Learning, 2015, 7(3):283-291, PMID: 25937853.

Gina Garrison Garrison G, Baia P, Canning J, Strang A. An asynchronous learning approach for the instructional component of a dual-campus pharmacy resident teaching program. American Journal of Pharmaceutical Education, 2015, 79(2):29, PMID: 25861110.

Michael Kane Saroka RM, Kane MP, Busch RS, Watsky J, Hamilton RA. SGLT-2 inhibitor therapy added to GLP-1 agonist therapy in the management of T2DM. Endocrine Practice, 2015, 21(12):1315-22.

David Kile Rudd K, Goss J, Engle A, Kile D. Increasing hospital pharmacist clinical competence in intensive pharmacotherapeutics using a novel pharmacist clinical educational program. Hospital Pharmacy, 2015, 50(9):776-782.

Nicole Lodise Rafie S, Shealy K, Borgelt L, Forinash A, Shrader S, Koepf E, McClendon K, Griffin B, Horlen C, Karaoui L, Rowe E, Lodise NM, Wigle P. Roles of the pharmacist in the use of safe and highly effective

PR ESID E N T ’S RE PORT

long-acting reversible contraception: An opinion of the women’s health practice and research network of the American College of Clinical Pharmacy.

Pharmacotherapy 2014; 34 (9): 991-999.

McBane SE, Borgelt LM, Barnes KN, Westberg SM, Lodise NM, Stassinos M. Use of compounded bioidentical hormone therapy in menopausal women: An opinion statement of the women’s health practice and research network of the American College of Clinical Pharmacy.

Pharmacotherapy 2014; 34(4): 410-423.

Thomas Lodise Kauf TL, McKinnon P, Corey GR, Bedolla J, Riska PF, Sims M, Jauregui-Peredo L, Friedman B, Hoehns JD, Mercier RC, Garcia-Diaz J, Brenneman SK, Ng D, Lodise T. An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.

BMC Infectious Diseases 2015 Nov 7;15:503. doi: 10.1186/s12879-015-1261-9.

PubMed PMID: 26547411; PubMed Central PMCID: PMC4637139.

Culshaw D, Lamp KC, Yoon MJ, Lodise TP. Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Diagnostic Microbiolo-

gy and Infect Disease 2015 Oct;83(2):193-7. doi: 10.1016/j. diagmicrobio.2015.06.003.

Epub 2015 Jun 11. PubMed PMID: 26184127.

Zasowski E, Bland CM, Tam VH, Lodise TP. Identification of optimal renal dosage adjustments for high-dose extended-infusion cefepime dosing regimens in hospitalized patients. Journal of Antimicrobial Chemotherapy 2015 Mar;70(3):877-81. doi: 10.1093/jac/dku435.

Epub 2014 Nov 6. PubMed PMID: 25381169.

Lodise TP, Anzueto AR, Weber DJ, Shorr AF, Yang M, Smith A, Zhao Q, Huang X, File TM. Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials. Antimicrobial Agents and Chemotherapy 2015 Feb;59(2):1119-26. doi: 10.1128/AAC.03643-14. Epub 2014 Dec 8. PubMed PMID: 25487791; PubMed Central PMCID: PMC4335888.

Shorr AF, Lodise TP, Corey GR, De Anda C, Fang E, Das AF, Prokocimer P. Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrobial Agents and Chemotherapy 2015 Feb;59(2):864-71. doi: 10.1128/AAC.0368814. Epub 2014 Nov 24.

PubMed PMID: 25421472; PubMed Central PMCID: PMC4335893.

Casapao AM, Lodise TP, Davis SL, Claeys KC, Kullar R, Levine DP, Rybak MJ. Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis. Antimicrobial Agents and Chemotherapy 2015;59(6):2978-85. doi: 10.1128/AAC.03970-14. Epub 2015 Mar 9. PubMed PMID: 25753631; PubMed Central PMCID: PMC4432113.

Lodise TP, Fan W, Sulham KA. Hospital admission patterns in adult patients with skin and soft tissue infections: Identification of potentially avoidable hospital admissions through a retrospective database analysis. Hospital Practice (1995) 2015;43(3):137-43. doi: 10.1080/21548331.

2015.1076325. PubMed PMID: 26224423.

Darius Mason Al-Sofiani ME, Jammah A, Racz M, Khawaja RA, Hasanto R, El-Fawal HAN, Mousa SA, Mason DL. Effect of Vitamin D supplementation on glucose control and inflammatory response in type II diabetic patients: double blind, randomization clinical trial. International Journal of Endocrinology and Metabolism, 2015, 13(1), PMID: 25745497.

Phelps KR, Mason DL, Stote KS. Parameters of phosphorus homeostasis at normal and reduced GFR: empiric observations. Clinical Nephrology, 2015, PMID: 25707455.

Phelps KR, Mason DL. Parameters of phosphorus homeostasis at normal and reduced GFR: theoretical considerations. Clinical Nephrology, 2015, PMID: 25685872.

Mathew RO, Mason DL, Tryniszewski T, Kennedy J. Antibody response following boost with Hepatitis B vaccine correlates with presence of intrinsic T-regulatory cells in hemodialysis patients. Hemodialysis International, Jun 23 2015, DOI: 10.1111/hdi.12326, PMID: 26104830.

Patrick Meek Triller D, Wymer S, Meek P, Hylek E, Ansell J. Trends in Warfarin Monitoring Practices Among New York Medicare Beneficiaries, 2006–2011. Journal of Community Health, 2015, 40(5):845-854, PMID: 26198584.

Amy Barton Pai Pai AB, Grabe DW, Eisele G, Patel H, Kubotera S, Prokopienko A, Nolin T. Changes in plasma levels of asymmetric dimethylarginine in chronic kidney disease patients treated for 8 weeks with the Vitamin D receptor agonist paricalcitol. Journal of Research and Development, 2015, 3:2.

Jang S, Prokopienko AJ, Grabe DW, Cerulli J, Fox C, Vassalotti J, Pai AB. NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011. Preventing Chronic Disease, Dec 18 2014, 11:E220 PMID:25523351.

in adults. Antimicrobial Agents Chemotherapy, 2015, 59(11):7094-6, PMID: 26282426.

Hong J, Kropp LC, Johns T, Pai MP. Individual vancomycin dosing in obese patients: A two-sample measurement approach improves target attainment. Pharmacotherapy 2015, 35(5):455-63, PMID: 26011138.

Justo JA, Mayer S, Pai MP, Soriano M, Danziger LH, Novak R, Rodvold KA. Pharmacokinetics of ceftaroline in normal body weight and obese (Classes I, II, and III) healthy adult subjects. Antimicrobial Agents Chemotherapy, 2015, 59(7):3956-65, PMID: 25896707.

Pai MP, Cojutti P, Pea F. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: A step toward dose optimization for the treatment of severe gram-negative bacterial infections.

Clinical Pharmacokinetics, 2015, 54(9):933-41, PMID: 25850987.

Zheng HA, Truong J, Carroll F, Pai MP. Do differences between reference listed drug and generic products of Piperacillin-tazobactam affect reconstitution? Antimicrobial Agents Chemotherapy, 2015, 59(3):1767-9, PMID: 25512410.

Amit Pai Pai MP. Treatment of bacterial infections in obese patients: How to appropriately manage the dosage. Current Opinion in Pharmacology, 2015, 24:1217, PMID: 26119488.

Nimish Patel Patel N, Assimon MM, Bruni E, McNutt LA, Mason DL. Incidence and clinical predictors of non-response to Hepatitis B vaccination among patients receiving hemodialysis: Importance of obesity. Southern Medical Journal, 2015, PMID: 26332483.

White B, Lomaestro B, Pai MP. Optimizing the initial amikacin dosage

Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt LA, Roman M, Miller CD.

Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment among HIV and Hepatitis C coinfected patients. AIDS Research and Human Retroviruses, Feb 2015, 31(2):18997, PMID: 25708155.

Patel N, Nasiri M, Koroglu A, Bliss S, Davis M, McNutt LA, et al. A cross-sectional study comparing the frequency of drug interactions after adding simeprevir- or sofosbuvir-containing therapy to medication profiles of Hepatitis C monoinfected patients. Infectious Diseases and Therapy, 2015, 4(1):6778, PMID: 25708155.

Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: A national cohort study of veterans affairs patients. Clinical Infectious Diseases, Jun 10 2015, pii: civ444, PMID: 26063715.

Sarah Scarpace Scarpace SL. Metastatic squamous cell non-smallcell lung cancer (NSCLC): Disrupting the drug treatment paradigm with immunotherapies. Drugs in Context 2015; 4: 212289.

DOI: 10.7573/dic.212289.

Kimberly Skylstad Garren T, Skylstad K. Scaffolded online learning modules for milliequivalency and milliosmolarity calculations. Currents in Pharmacy Teaching and Learning (in press).

Aimee Strang Strang AF, Baia P. How effective are pharmacy teacher training programs?

A comprehensive review of teaching and learning programs in pharmacy education. The American Journal of Pharmaceutical Education (In Press).

Baia P, Strang AF. A five year study: Pharmacy

educator motives to pursue pedagogical knowledge.

The American Journal of Pharmaceutical Education (In Press).

Fuentes DG, Ogden RR, Ryan-Haddad A, Strang AF. Reframing our pursuit to work/life balance. The American Journal of Pharmaceutical Education 2015; 79(3): 34.

CASE R EPORTS AND R EVIEW ARTICLES Katherine Cabral Boden WE, Padala SK, Cabral KP, Buschmann I, Sidhu MS. The role of short-acting nitroglycerin in the management of ischemic heart disease. Drug Design, Development and Therapy 2015; 9:4793-4805.

Cabral KP, Ansell JE. The role of factor Xa inhibitors in VTE treatment. Journal of Vascular Health and Risk Management, Jan 2015; 11:117-123.

Clayton English English C, Aloi JJ. New FDA-approved diseasemodifying therapies for multiple sclerosis. Clinical Therapeutics, 2015, 37(4): 691-715, PMID: 25846320.

D’Agostino A, English C, Rey JA. Vortioxetine (Brintellix®): A new serotonergic antidepressant. P&T 2015, 40 (1):36-40, PMID: 25628505.

Jessica Farrell Toledo A, Shapiro L, Farrell J, Magro C, Polito J. Laparoscopy shows superiority over endoscopy for early detection of malignant atrophic papulosis gastrointestinal complications: A case report and review of literature. BMC Gastroenterology, 2015, 15(1), PMID: 26527039.

Robert Hamilton Saroka R, Kane M, Busch R, Watsky J, Hamilton R. SGLT2 inhibitor therapy added to GLP-1 agonist therapy in the management of T2DM. Endocrine Practice, 2015, PMID: 26307900.

Nicole Lodise Stone RH, Lodise NM, Morin AK, et al. What is the restriction on over-the-counter emergency contraception access today? Journal of Adolescent Health 2014; 55(1).

Amy Barton Pai Pai AB. Keeping kidneys safe: The pharmacist’s role in NSAID avoidance in high-risk patients. Journal of the American Pharmacists Association, Jan 1 2015, 55(1):e15-25, PMID: 25503987.

Pai AB. Evaluating plasma pharmacokinetics of IV iron formulations: Judging books by their covers?

Clinical Pharmacokinetics, 2015, 54(4):323-4, PMID: 25445844.

Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S, On behalf of the American Society of Nephrology Dialysis Advisory Group. Considerations and challenges in defining the optimal utilization of iron in dialysis-dependent chronic kidney disease.

Invited Commentary, Journal of the American Society of Nephrology, 2015, 26(6):1238-1247, PMID: 25542967.

Joanna Schwartz Ji Y, Schwartz J, Hartford A, Ramsey J, Phillips J, Verschraegen C. Successful treatment of non–small cell lung cancer with erlotinib throughout pregnancy.

JAMA Oncology, 2015, 1(6):838, PMID: 26181671.

See-Won Seo Gleason SE, Covvey JR, Abrons JP, Dang Y, Seo S, Tofade T, Prescott GM, Peron EP, Masilamani S, Alshari NZ. Connecting global/international pharmacy education to the CAPE 2013 outcomes: A report from the global pharmacy education special interest group.

56 p. AACP Center for

AC P H S P RE SID E N T’ S RE PO RT 23

the Advancement of Pharmacy Education, Alexandria, VA. BO O K S Robert DiCenzo DiCenzo, R., Ed (2015).

Clinical Pharmacist’s Guide to Biostatistics and Literature Evaluation: Second Edition. Lenexa, KS: American College of Clinical Pharmacy.

BO O K C HA P TERS Michael Brodeur Brodeur MR. “Geriatric Disorders” in Fundamentals of Geriatric Pharmacotherapy: An Evidence Based Approach. Hutchinson Sleeper, ed., 2nd Edition, 2015.

Taggart A, Estus E, Boumeester C, Emptage R, Lee J, Mahan R, Slattum PW, Vouri SM, Brodeur MR, Niehoff KM. Geriatric Pharmacy Curriculum Guide, 3rd Edition 2015. American Society of Consultant Pharmacists, 2015.

Brian Cowles Cowles B. “Preventing medication errors and harm in children” in Ferri’s Clinical Advisor: Instant Diagnosis and Treatment. Ferri FF, editor, Philadelphia: Mosby Elsevier, 2015, e896.

Robert DiCenzo DiCenzo R. “Biostatistics” in Pediatric Pharmacy Preparatory Review Course (pp. 21-28). Lenexa, KS, American College of Clinical Pharmacy, 2015.

DiCenzo R. Biostatistics.

Fundamentals of Bisostatistics and Clinical Trial Design. Updates in Therapeutics (pp. 5-50). Lenexa, KS, American College of Clinical Pharmacy, 2015.

Jessica Farrell Farrell JF, Kennedy AG. “Psoriatic Arthritis” in Ambulatory Care SelfAssessment Program (ACSAP), 2016 Book 1, Endocrinologic/Rheumatologic Care. Dong BJ, Elliott DP, eds., Lenexa,

24 AC PHS

KS, American College of Clinical Pharmacy.

Darren Grabe Grabe DW, Cardone KE. “Altered pharmacology and pill burden in the elderly: A balancing act” in Handbook of Dialysis in the Elderly, M. Misra (Ed.), Philadelphia, PA, Springer Healthcare LLC. Grabe DW. “Hypertension Management” in Nephrology pharmacotherapy: A pharmacist’s guide to advanced kidney disease and medication management, J. Hudson & D. Mason (Eds).

Michael Kane Kane MP. “Hyperthyroidism: Graves’ Disease” in Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach, 4th Edition. Katz M, Matthias KR, ChisholmBurns MA, eds., New York, NY, McGraw Hill, 2015.

Kane MP. “Endocrine Disorders” in Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course 2015 ed (pp 1-39- 1-96). Bainbridge JL, Branham, A, Coyle EA, et al, eds., Lenexa, KS, American College of Clinical Pharmacy, 2015.

Nicole Lodise Lodise NM, Sutton E. “Sexual Dysfunction” in American College of Clinical Pharmacy - Ambulatory Care Self-Assessment Program (ACCP- ACSAP) 2015 Book 2 (Women’s and Men’s Care).

Patrick Meek Meek PD, Brodeur MR. “Palliative medicine issuesconstipation/diarrhea” in The Art and Science of Palliative Medicine. Smith H, ed., 2015.

Amy Barton Pai Pai AB, Wegrzyn N. “Acute Kidney Diseases” in Drug-Induced Diseases, Prevention, Detection and Management, 3rd

PR ESID E N T ’S RE PORT

edition. Tisdale J, Miller D, eds., 2015 American Society of Health-systems Pharmacists, Bethesda, MD, 2015.

Pai AB. “Disorders of Calcium and Phosphorus Homeostasis” in Pharmacotherapy: A Pathophysiologic Approach, Tenth Edition.

DiPiro J et al eds., Mcgraw Hill, 2015.

Pai AB. “Iron Oxide Nanoparticles for Treatment of Anemia of Chronic Kidney Disease: Too Much of a Good Thing?” in Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety and Risk. R. Bawa (Editor), G. F. Audette and B. E. Reese. (Assistant Editors), Pan Stanford Publishing, Singapore [ISBN 978-9814669-22-1] 2015.

John Polimeni Polimeni J, Mayumi K. “The Reality of Nuclear Power: Reflections After Fukushima” in The Oxford Handbook of the Macroeconomics of Global Warming. W. Semmler and L. Bernard, eds., Oxford University Press, 2015.

Sarah Scarpace Scarpace, SL. “Oncology” in Updates in Therapeutics®: The Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2015 ed., Volume 1. Bainbridge JL, Branham A, Coyle EA, et al, eds., pp 415-549, Lenexa, KS, American College of Clinical Pharmacy, 2015.

Scarpace, SL. “Supportive Care in Oncology” (Chapter 99) in Pharmacotherapy: Principles and Practice, 4th ed. Chisoholm-Burns M, Schwinghammer TL, Wells BG, Malone PM, Kolesar JM, and DiPiro JT eds., New York: McGraw-Hill 2015 (In Press).

Emily Sutton Lodise NM, Sutton E. “Sexual Dysfunction” in American College of Clinical Pharmacy - Ambulatory Care

Self-Assessment Program (ACCP- ACSAP) 2015 Book 2 (Women’s and Men’s Care).

CONFERENCE PRESENTATIONS SCIENTIFIC POSTER S Monique Bidell Polnak JF, Kennicutt J, Bidell MR. Appropriateness of empiric antibiotic prescribing practices for hospitalized patients with urinary tract infections. American Society of Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA, December 2015.

Laurie Briceland Briceland LL, Kane T, Jablanski C. Analysis of ‘Habits of Mind’ cultivated via curricular threading through skills labs and APPEs. American Association of Colleges of Pharmacy (AACP) Annual Meeting Abstract, National Harbor, MD, July 2015.

Scarpace SL, Briceland LL, Feinberg D. Pharmacist in Training (PhiT) portfolio.

AACP Annual Meeting School Poster Abstract, National Harbor, MD, July 2015.

Cai W, Zheng H, DiLorenzo J, Briceland LL, Hao A. A China-US exchange program for clinical pharmacy experiential education: A 6-year report. AACP Annual Meeting Abstract, National Harbor, MD, July 2015.

Michael Brodeur Blaszczyk A, Estus E, Bouwmeester C, Emptage R, Lee J, Mahan R, Slattum P, Vouri S, Brodeur M, Niehoff K. Developing a geriatric pharmacy curriculum guide, 3rd edition. American Society of Consultant Pharmacists Annual Meeting, Las Vegas, NV, November 2015.

Blaszczyk A, Estus E, Bouwmeester C, Lee J, Mahan R, Brodeur M, Niehoff K. Using the new ASCP geriatric pharmacy curriculum guide: A brand new approach to seeking

professional competency in geriatrics. American Society of Consultant Pharmacist Annual Meeting, Las Vegas, NV, October 31, 2015.

Blaszczyk A., Estus E., Bouwmeester C., Emptage R., Lee J., Mahan R., Slattum P., Vouri S., Brodeur M., Niehoff K. Developing a Geriatric Pharmacy Curriculum Guide, 3rd Edition.

American Geriatrics Society Annual Meeting, National Harbor, MD, May 2015.

Jeffrey Brewer Strang A, Brewer J, Lubowski T, Brodeur M, Sutton E, Seo S. Assessment of an instructional design change: Peer-led vs Faculty-led SOAP note instruction. American Association of Colleges of Pharmacy (AACP) Annual Meeting, National Harbor, MD, July, 2015.

Jo Carreno Carreno JJ, Sutton E, Schulz K, DiCenzo R. Quarterly variation in respiratory fluoroquinolone and macrolide prescribing among outpatient Medicaid enrollees in Vermont, 2004 - 2014.

ICAAC/ICC 2015, San Diego, CA, September 2015.

Jennifer Cerulli George J, Houser K, Roberts A, Cerulli J. Development of a quality assurance process to maximize targeted intervention opportunities in a supermarket pharmacy chain. APhA Annual Meeting, San Diego, CA, March 2015.

Debra Feinberg Feinberg DF, Lubowski T, Sidlauskas K. Assessing Health and Wellness (HW) IPPE utilizing rubric grading of student projects and reflection summaries. American Association of Colleges of Pharmacy (AACP) Annual Meeting Abstract, National Harbor, MD, July 2015.

Michael Kane Stryker M, Kane MP, Busch RS, Hamilton RA. Evaluating the off-label use

of once-weekly exenatide in combination with basal insulin therapy in patients with type 2 diabetes mellitus (Poster #388595). ASHP Midyear Clinical Meeting, New Orleans, Louisiana, December 9, 2015.

Thomas Lodise Lodise TP, Ye M, Zhao Q. Relationship between cumulative number of prior antibiotic exposures and carbapenem resistance among patients with hospital-onset infections due to enterobacteriaceae spp (Abstract # 1793). IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, San Diego, CA, October 7-11, 2015. Presenter: Lodise.

Bhagnani T, Lodise TP, Wang R, Bhurke S, Zhao Q, Berger A. Patterns of empiric antibiotic therapy among hospitalized patients with complicated intra-abdominal infections or complicated urinary tract infections due to enterobacteriaceae (Abstract # 160). IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, San Diego, CA, October 7-11, 2015. Presenter: Lodise.

Wang R, Lodise TP, Bhagnani T, Zhao Q, Bhurke S, Berger A. Clinical and economic burden of hospitalized patients with serious infections due to Carbapenem Resistant Enterobacteriaceae (Abstract # 1835). IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS, San Diego, CA, October 7-11, 2015. Presenter: Zhao.

Mckinnell JA, Griffin M, Humphries R, Hindler J, Crowley O, Bedassie S, Stephenson K, Garland C, Lodise TP. Distribution of Gram-Negative (GN) pathogens and Carbapenem Resistance (CR) patterns across United States hospitals: Will klebsiella become the new pseudomonas? (Abstract # 1788). IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS,

San Diego, CA, October 7-11, 2015. Presenter: Mckinnell.

Berger A, Wang R, Zhao Q, Bhagnani T, Bhurke S, Lodise T. Length of stay in hospital associated with empiric use of antibiotics with microbiologic activity against CarbapenemResistant Enterobacteriaceae (Abstract # S-1347).

Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) Joint Meeting, San Diego, CA, September 17-21, 2015. Presenter: Lodise.

Bhurke S, Lodise T, Bhagnani T, Zhao Q, Wang R, Berger A. Costs to treat serious infections due to Carbapenem-resistant Enterobacteriaceae in United States (US) hospitals (Abstract # S-1337).

Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) Joint Meeting, San Diego, CA, September 17-21, 2015. Presenter: Berger.

Rhodes NJ, Prozialeck W, Lodise T, Venkatesan N, O’Donnell JN, Pais G, Lamar P, Gulati A, Kamilar JM, Scheetz M. Vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury (Abstract # A-977).

Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) Joint Meeting, San Diego, CA, September 17-21, 2015. Presenter: Rhodes.

Lodise TP, Travers KU, Martin AL, Ashaye AO, Zhao Q, Dixit S. Association between inappropriate empiric treatment or delayed appropriate treatment and health outcomes among patients hospitalized with infections due to Klebsiella pneumoniae: How long is too long? (Abstract # 7107).

SHEA Spring Conference, Orlando, FL, May 14-17, 2015. Presenter: Lodise.

Lodise TP, Ye M, Dixit S, Zhao Q. Prevalence of invasive Gram-negative Infections due to Carbapenem-resistant Enterobacteriaceae among adult patients in US intensive care units (Abstract # 7121). SHEA Spring Conference, Orlando, FL, May 1417, 2015. Presenter: Lodise.

Darius Mason Cichewicz A, Mason DL, Hudgen E, Gallagher J, El-Fawal HA. Association of Neuroantibodies (NAB) with Glutathione-S-Transferase (GST) Isozyme Polymorphisms (SNP) in African-American children with heavy metal exposure.

54th Annual Meeting of the Society of Toxicology, San Diego, CA, March 2015.

Phelps KR, Mason DL, Kang S. Attributes of the Walton-Bijvoet nomogram at normal and reduced GFR. American Society of Nephrology Renal Week, San Diego, CA, Fall 2015.

Phelps KR, Mason DL. An investigation of the inverse relationship between FEP and TmP/GFR. American Society of Nephrology Renal Week, San Diego, CA, Fall 2015.

Phelps KR, Mason DL, Kang S. FEP misrepresents effects of PTH and FGF23 on P reabsorption in CKD. American Society of Nephrology Renal Week, San Diego, CA, Fall 2015.

Patrick Meek Meek PD, Parker WM, Racz MJ, Cosler LE, Teynor ME. Differentiating oral mesalamine adherence patterns in ulcerative colitis patients: A group-based trajectory model approach. Advances in Inflammatory Bowel Diseases: Crohn’s & Colitis Foundation’s Clinical and Research Conference, Orlando, FL, December 2015.

Pavilack M, Meek PD. Medication adherence in patients with inflammatory bowel disease: A review of the literature. Academy of Managed Care Pharmacy Annual Meeting & Expo, San Diego, CA, April 2015.

Hwang YN, Meek PD. Association of mental health comorbidity with analgesic prescribing behaviors in the emergency department setting. Academy of Managed Care Pharmacy: NEXUS Meeting, Orlando, FL, October 2015.

Amy Barton Pai Raouf M, Kelsey T, Wilming C, Cabral K, LaFleur C, Pai AB. A student pharmacist-led public health initiative for early identification of cardiovascular and kidney disease risk factors. American College of Clinical Pharmacy Global Conference, San Francisco, CA, October 19, 2015.

Pai AB, Meyer D, Bales B, Cotero V, Pai A, Zheng N, Jiang W. Labile iron release from intravenous (IV) iron formulations: Considerations for bioequivalence.

National Kidney Foundation Spring Clinical Meeting, Dallas, TX, March 27, 2015.

Pai AB, Cardone K, Daoui R, Salenger P, Chen X, Kao T, Boverman G, Davenport D. Utility of bioelectrical impedance spectroscopy (BIS) with electrical impedance tomography (EIT) to evaluate regional volume flux in hemodialysis (HD) patients.

National Kidney Foundation Spring Clinical Meeting, Dallas, TX, March 27, 2015.

Pai AB, Narsipur S, Goldstein L. Lipoteichoic acid as a non-invasive marker of biofilm burden in hemodialysis (HD) patients. National Kidney Foundation Spring Clinical Meeting, Dallas, TX, March 27, 2015.

Nimish Patel Britt NS, Potter EM, Patel N, Steed ME. Association be-

tween time to treatment and clinical outcomes in vancomycin-resistant enterococcal bloodstream infection (Abstract #2570). 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 2015.

Jakeman B, Nasiri M, Ruth L, Morse C, Mahatme S, Patel N (Abstract #H780; Presenter: Patel). 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 2015.

Sarah Scarpace Azar D, Scarpace SL. Factors that influence time to start oral chemotherapy. American Society of Health-systems Pharmacy (ASHP) Midyear meeting, resident poster session, Session ID 387240, December 6, 2015, New Orleans, LA. Scarpace SL, Briceland LL, Feinberg D. Pharmacist in Training (PhiT) portfolio.

AACP Annual Meeting School Poster Abstract, National Harbor, MD, July 2015.

Joanna Schwartz Ji Y, Schwartz J, Verschraegen C. The treatment of lung cancer during pregnancy.

Annual Meeting of the Northern New England Chapter of the American Society of Clinical Oncology, Bretton Woods, NY, October 2015.

Kimberly Skylstad Garren T, Skylstad K. Differentiated and flexible learning environment for calculations in a pharmacy skills lab. Northeastern Educational Research Association Annual Conference, Trumbull, CT, October 2015.

See-Won Seo Strang AF, Brewer J, Lubowski T, Brodeur M, Sutton E, Seo S. Assessment of an instructional design change: Peer-led vs. Faculty-led SOAP note instruction.

Midyear Meeting of the American Association of Col-

AC P H S P RE SID E N T’ S RE P O RT 25

leges of Pharmacy, National Harbor, MD, July 2015.

Aimee Strang Strang AF, Brewer JM, Lubowski TJ, Brodeur MR, Sutton E. Assessment of an instructional design change: Peer-led vs Faculty led SOAP note instruction. AACP Midyear Meeting, National Harbor, MD, July 2015.

Emily Sutton Sutton E, Strang AF, Brewer J, Lubowski T, et al. Assessment of an instructional design change: Peer-led vs. Faculty-led SOAP note instruction. Midyear Meeting of the American Association of Colleges of Pharmacy, National Harbor, MD, July 2015.

INVITED P R E S E N TAT I O NS Michael Biddle Immunizations Update.

ACPHS Pharmacy Practice Institute, Albany, NY, April 19, 2015.

Biddle MA, Friend C. The Pharmacist’s Role in Rural Communities. Vermont Farm Health Task Force’s Agricultural Medicine Training Course, Burlington, VT, September 23, 2015.

Monique Bidell Urinary tract infections: Where are we now? ACPE accredited continuing education, Albany College of Pharmacy and Health Sciences, Albany, NY, April 2015.

Abby Boire Boire AM, English CD. Common Medication Interactions. Invited presentation to the Obstetrics/Gynecology and Family Medicine Departments at the University of Vermont Medical Center, Burlington, VT, March 2015.

Michael Brodeur Medication Management in Older Adults. Albany Guardian Society, Albany NY, July 2015.

Blaszczyk A, Estus E, Bouwmeester C, Lee J,

26 AC PHS

Mahan R, Brodeur M, Niehoff K. Using the new ASCP geriatric pharmacy curriculum guide: A brand new approach to seeking professional competency in geriatrics. American Society of Consultant Pharmacist Annual Meeting, Las Vegas, NV, October 31, 2015.

Kate Cabral Advances in Antithrombotic Therapy. Presented for Capital Testing Services LLC, Spring Pharmacy CE Series. Albany, NY and Syracuse, NY. April 2015.

Jo Carreno Infectious Diseases Update.

Pharmacist Society of the State of New York (PSSNY) Mid-Winter Conference, Saratoga Springs, NY, February 2015.

Jennifer Cerulli Advantages of a Health Information Exchange for Pharmacists (1 hour ACPE).

Albany College of Pharmacy and Health Sciences, Albany, NY, April 19, 2015.

Utilizing GOLD Guidelines to Improve COPD Outcomes (2 hours, ACPE # 0280-0000-15-026-L01-P).

PharmEd, Albany, NY, April 30, 2015.

Robert DiCenzo Pediatric pharmacy preparatory review course: Biostatistics. American College of Clinical Pharmacy - Updates in Therapeutics.

Rosemont, IL, April 10, 2015.

Fundamentals of biostatistics and clinical trial design.

American College of Clinical Pharmacy - Updates in Therapeutics. Rosemont, IL, April 10-14, 2015.

Course. Burlington, VT, June 2015.

Week Conference, Vienna, Austria, September 15, 2015.

Clayton English The pharmacy perspective: How providers might counsel patients on medical marijuana. Continuing Education presentation at the Alden March Bioethics Institute Clinical Ethics Conference, Albany, NY, November 2015.

What’s the Latest Breaking in Rheumatoid Arthritis?

American College of Rheumatology Annual Scientific Meeting - Association of Rheumatology Health Professionals Pre-Meeting Course, San Francisco, CA, November 7, 2015.

Management of neuropsychiatric symptoms associated with Alzheimer’s Disease. Continuing Education presentation at Albany College of Pharmacy and Health Sciences, Colchester, VT, October 2015.

Personalized precepting: Strategies for teaching students and residents at different levels within pharmacy practice. Continuing Education presentation at Albany College of Pharmacy and Health Sciences, Albany, NY, August 2015.

Jessica Farrell The Role of Biologic Therapy in the Management of Rheumatoid Arthritis.

10th Annual Clinical Pharmacy Week Conference, Vienna, Austria, September 14, 2015.

The Role of Biologic Therapy in the Management of Psoriatic Arthritis.

10th Annual Clinical Pharmacy Week Conference, Vienna, Austria, September 14, 2015.

Giselle D’Epiro The Skinny on Weight Loss Treatment. Vermont Society of Health Systems Pharmacy Spring Conference, Burlington, VT, April 2015.

Case Workshop: A Focus on Biologics in Rheumatoid Arthritis. 10th Annual Clinical Pharmacy Week Conference, Vienna, Austria, September 14, 2015.

New Biologic Therapies: A Focus on Novel Targets and Cost-Effectiveness. 10th Annual Clinical Pharmacy Week Conference, Vienna, Austria, September 15, 2015.

New Drug Update: Focus on Weight Loss and Insomnia Family Medicine Review

Biologics: Challenges, Limitations, and the Future. 10th Annual Clinical Pharmacy

PR ESID E N T ’S RE PORT

Association’s Diabetes Summit - Diabetes and the Older Adult, Scotia, NY, November 4, 2015.

GLP-1 Agonists, SGLT-2 inhibitors and New Insulins: An Update in the Management of Diabetes.

Vermont Pharmacists Association, Montpelier, VT, May 31, 2015.

Pharmacotherapy: What’s New in Rheumatology?

American College of Rheumatology Annual Scientific Meeting, San Francisco, CA, November 10, 2015.

GLP-1 Agonists, SGLT-2 inhibitors and “I did inhale”: An Update in the Management of Diabetes. ACPHS Pharmacy Practice Institute, Albany, NY, April 19, 2015.

Updates in pharmacotherapy: A focus on rheumatoid arthritis and psoriatic arthritis.

Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course, ACCP Annual Meeting, Rosemont, IL, April 10, 2015.

Presented to rheumatologists, rheumatology health professionals, and pharmacy students at the Center for Rheumatology. Albany, NY, November 17, 2015.

Elizabeth Higdon Blood Glucose Monitoring Workshop (1 contact hour CE). Vermont Pharmacists Association (VPA) Spring Meeting, Montpelier, VT, May 2015.

Higdon ER. Diabetes Devices. University of Vermont Medical Center, Burlington, VT, December 2015.

Michael Kane Diabetes Update. Central New York Chapter of the New York State Council of Health-system Pharmacists, Syracuse, NY, November 18, 2015.

Effective strategies to reduce adverse drug events: Prevention of hypoglycemia in the elderly. New York State Chapter of the American College of Clinical Pharmacy’s Fall Clinical Meeting, Albany, NY, November 13, 2015.

Diabetes medications: Guidelines for use in the older adult. Upstate New York American Diabetes

Nicole Lodise A Pragmatic and Practical Guide to Get People to Stop Smoking. Outpatient Management of the BIG 7 in our Changing Healthcare Environment: Optimizing Care Using ACO’s/Medical Homes and Minimizing Readmissions, Troy, NY, March 2015.

Women’s Health in the News (1.5 hour CE program).

Barbara M. DiLascia Women’s and Men’s Health Symposium, Albany College of Pharmacy and Health Sciences, Albany, NY, October 2015.

Tobacco Cessation: Tips to assist your patient in quitting (1.5 hour CE program). Vermont Pharmacists Association Fall Meeting, Colchester, VT, October 2015.

Thomas Lodise New Antimicrobial Update.

New York State Chapter of the American College of Clinical Pharmacy Fall Clinical Meeting, November

13, 2015, Albany, NY. Treatment of MRSA bloodstream infections in the 21st century. Infectious Diseases Monthly Meeting, November 5, 2015, Calgary, ALB. Approaches to drug dose optimization. IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. Session Title: Antimicrobial Advances that Will Change Your Practice. Session Type: Symposium. October 8, 2015, San Diego, CA. Antimicrobial Advances that Will Change Your Practice: Gram-Negatives.

IDWeek2015: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. Session Title: Antimicrobial Advances that Will Change Your Practice.

Session Type: Symposium.

October 8, 2015, San Diego, CA. Vancomycin PK/PD Efficacy.

American College of Clinical Pharmacology. Session Title: Vancomycin: Is There Anything Left to Know?

Session Type: Symposia.

September 27, 2015, San Francisco, CA. Pharmacodynamic profiling of antibiotics in patients with lower respiratory tract infections. Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) Joint Meeting.

Session Title: Pharmacokinetics/Pharmacodynamics (PK/PD) of the Lung.

Session Type: Workshop.

September 17, 2015, San Diego, CA. All the things you were told about antibiotic dosing over the years that were wrong. University of Florida School of Pharmacy, August 7, 2015, Gainesville, FL. Quantifying antibiotic exposure-effect relationships in patients with infections: A focus on beta-lactams and vancomycin. Institute for Therapeutic Innovation

within the Department of Medicine at the University of Florida, Orlando, FL, August 6, 2015.

Dose optimization opportunities in critically ill patients. Symposium by the Infectious Disease Association of California (IDAC), in association with the California Department of Public Health entitled, “Practical Antimicrobial Stewardship: Implementation and Expansion in Healthcare Facilities,” July 17, 2015, Irvine, CA. Advanced Pharmacokinetics/Pharmacodynamics.

ACPE accredited continuing education, New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, July 29-30, 2015, New York, NY. Combination therapy for serious gram-negative infections. ACPE accredited continuing education, New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, July 29-30, 2015, New York, NY. New antimicrobial update.

Infectious diseases grand rounds at Stratton Veterans’ Affairs Medical Center, June 25, 2015, Albany, NY. Advanced pharmacokinetics/pharmacodynamics.

ACPE accredited continuing Education, New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, May 18-19, 2015, New York, NY. Combination therapy for serious gram-negative infections. ACPE accredited continuing education, New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, May

18-19, 2015, New York, NY. Combination therapy for serious gram-negative infections: “Myth or Reality”. 33rd Annual UC Davis Health System Infectious Diseases Conference, February 6, 2015, Sacramento, CA. New antimicrobial update.

ACPE accredited continuing education, Albany College of Pharmacy and Health Sciences, February 8, 2015, Albany, NY. Amy Barton Pai Biosimilars and non-biologic complex drugs: Current issues. Northeast Kidney Foundation Kidney Care Conference, Excelsior Springs, Saratoga, NY, November 1, 2015.

Are we reaching our full potential in CKD care?

Medication management services in CKD. National Institutes of Health, Kidney Interagency Coordinating Committee, Bethesda, MD, September 25, 2015.

Pharmacist-led programs to improve medication safety in kidney disease.

4ª Jornada Integrada de Qualidade em Hemodiálise – Programação, São Paulo, Brazil, June 19, 2015.

Lipoteichoic acid: Potential as a non-invasive marker of biofilm burden. University of São Paulo, Department of Pharmaceutical Sciences, São Paulo, Brazil, June 19, 2015.

Clinical challenges with IV iron use in kidney disease.

GDUFA FY 2015 Regulatory Science Initiatives Part 15 Public Meeting, Silver Spring, MD, June 5, 2015.

Top ten reasons to have a pharmacist of the ESKD team. National Kidney Foundation Spring Clinical Meeting, Dallas, TX, March 25, 2015.

Top ten nephrotoxic drugs.

National Kidney Foundation Spring Clinical Meeting,

Dallas, TX, March 26, 2015.

Generic IV iron formulations: Black solutions in a regulatory gray area. National Kidney Foundation Spring Clinical Meeting, Dallas, TX, March 28, 2015.

Amit Pai Challenges of dosing antimicrobial in obesity.

Expert Panel on Obesity and Infection, Chicago, IL, November 2015.

Daptomycin dosing in critically ill patients. Infectious Diseases Conference, University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, ONT, October 2015.

Dosing strategies for obese patients in the ICU. Infectious Diseases Conference, University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, ONT, October 2015.

Vancomycin dosing in obesity: Is body weight the best descriptor? Annual Meeting of the American College of Clinical Pharmacology, San Francisco, CA, September 2015.

Pai MP, Hope W. (Conveners) I have a white powder but want a drug: Shepherding compounds through the Valley of Death, San Diego, CA, September 2015.

Antimicrobial dosing considerations in obese patients with chronic kidney disease.

CINE-HDC-Renal Class and University of Sao Paulo, Integrated Quality Symposium on Hemodialysis, Sao Paulo, Brazil, June 2015.

Finding the right dose and schedule to optimize antimicrobials. Argentine Society of Infectious Diseases Annual Meeting, Buenos Aires, Argentina, June 2015.

Treatment of resistant gram-positive bacteria: A pharmacologic perspective. Argentine Society of Infectious Diseases Annual Meeting, Buenos Aires, Argentina, June 2015.

Dosing regimen matters.

Continuing Education, Visiting Professorship, University of Illinois at Chicago, Chicago, IL, April 2015.

Antimicrobial dosing regimen matters. Continuing Education, Annual Infectious Diseases Program, Albany College of Pharmacy and Health Sciences, Albany, NY, February 2015.

Nimish Patel HIV resistance overview for providers – 2015. ACPE accredited continuing education telemedicine series broadcast to all New York State Department of Corrections pharmacists. Albany Medical Center HIV Clinic, Albany, NY, February 2015.

HCV Update 2015. Grand rounds to physicians at Nathan Littaeur Hospital, Gloversville, NY, February 2015.

What’s new in HCV pharmacotherapy. ACPE accredited continuing education, Albany College of Pharmacy and Health Sciences, Albany, NY, February 2015.

Sarah Scarpace HPV positive oropharyngeal cancer: Is it time to de-escalate therapy? 30-minute ACPE-accredited program presented to pharmacists at the American College of Clinical Pharmacy Annual Meeting. San Francisco, CA, October 19, 2015.

Practical issues with new targeted therapies for cancer. 1-hour ACPE-accredited program presented to pharmacists as part of the Association of Community Cancer Centers (ACCC) Oncology Pharmacy Education Network (OPEN) conference.

Charlotte, NC, July 10, 2015 / Fort Lauderdale, FL, June 26, 2015 / New Brunswick, NJ, May 15, 2015.

Hematology/Oncology.

1-hour ACPE-accredited program presented to pharmacists as part of the

AC P H S P RE SID E N T’ S RE PO RT 27

American College of Clinical Pharmacy (ACCP) Updates in Therapeutics 2015: Ambulatory Care Pharmacy Preparatory Review and Recertification Course. Chicago, IL, April 11, 2015.

Sivik J, Iacovelli L, Scarpace SL, Parsons K. Practice panel: Survivorship. 20-minute presentation as part of a 1.5-hour ACPE-accredited panel discussion presented to pharmacists at the Hematology/Oncology Pharmacy Association (HOPA) 11th Annual Meeting. Austin, TX, March 26, 2015.

Oncology new drug update.

1.5-hour ACPE-accredited CE program presented to pharmacists at the Capital Testing Services Pharmacy Clinical Practice and Law Update program. Holiday Inn Airport, Buffalo, NY, April 17, 2015; Holiday Inn Airport, Rochester, NY, April 18, 2015; Holiday Inn Express, Latham, NY, April 10, 2015.

Joanna Schwartz Herbal interactions with chemotherapy. Vermont Breast Cancer Symposium, Burlington, VT, October 2015.

See-Won Seo New Drug Update. ACPE accredited continuing education, Pharmacists Society of the State of New York, Saratoga Springs, NY, January 2016.

Aimee Strang Design, development, and implementation of a multi-campus online graduate elective for health pro-

fessionals. Conference on Higher Education Pedagogy, Blacksburg, VA, Feb 2015.

Emily Sutton Acute and long term complications of diabetes.

Presentation to Vermont Pharmacy Association, Montpelier, VT, 2015.

EXTRAMURAL GRANTS Jo Carreno Project: Impact of a Multidisciplinary Team on Time to Sepsis Resolution Grantor: ASHP Research and Education Foundation Amount: $75,000 Term: 5/1/15 - 10/31/16 Amy Barton Pai Project: A community based study of adverse effects of NSAIDs on the kidney and risk mitigation to reduce preventable harm Grantor: Food and Drug Administration Grant No.: BAA-15-00121 Amount: $203,733 Term: 9/30/15 - 7/31/17 Amit Pai Project: Single Dose Pharmacokinetics of Intravenous Tedizolid Phosphate in Morbidly Obese and Age-, Sex-, and Ideal Body WeightMatched Non-Obese Adults Grantor: Merck, Inc. Amount: $179,824 Term: 1/28/15 - until complete Nimish Patel Project: Prevalence of Contraindicated Drug-Drug Interactions between Sofosbuvir/Ledipasvir and Ombitasvir/Dasabuvir/ABT450/Ri-

tonavir +/- Ribavirin among Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Grantor: Gilead Sciences Amount: $26,720 Term: 4/1/15 - until complete Project: Prevalence of Contraindicated Drug-Drug Interactions after addition of Sofosbuvir / Ledipasvir and Ombitasvir/Dasabuvir/ ABT450/Ritonavir +/- Ribavirin to Medication Profiles of Patients with Chronic Hepatitis C Monoinfection Grantor: Gilead Sciences Amount: $36,371 Term: 4/1/15 - until complete

PROFESSIONAL APPOINTMENTS Michael A. Biddle. Appointed by Gov. Shumlin to the Vermont Medicaid Drug Utilization Review Board.

Michael R. Brodeur. Appointed by Gov. Cuomo to the New York Justice Center Medical Review Board.

Katherine P. Cabral. President-elect of the New York State chapter of the American College of Clinical Pharmacy (ACCP).

Andy Flynn. Appointed to the Editorial Board of the PSSNY journal New York Pharmacists Century II. Sarah L. Scarpace. Elected to three year term (2015 2018) as President-elect/ President/Past-President of the Hematology/Oncology Pharmacy Association (HOPA).

Jennifer Cerulli. American Pharmacists Association Medication Therapy Management (MTM) Evidence Advisory Panel.

Robert DiCenzo. President-elect of the APhA Academy of Pharmaceutical Research and Science.

Clayton English. Appointed

by Gov. Shumlin to the Vermont Medicaid Drug Utilization Review Board.

Gina D. Garrison. Executive Council, Rho Chi Pharmacy Honor Society.

Gina D. Garrison. Associate Editor, Currents in Pharmacy Teaching and Learning (term ended in 2015)

Andy Flynn. Region 7 Representative of the Pharmacists Society of Sate of New York (PSSNY).

Gina D. Garrison.

Public Policy Committee Member, New York State Council of Healthsystem Pharmacists.

Andy Flynn. Treasurer of the Capital Area Pharmacists Society (CAPS).

Michael P. Kane. Editorial Board Member of Case Reports in Endocrinology.

Andy Flynn. Member of the Blue Shield of Northeastern New York P&T Committee.

Michael P. Kane. Northeast Kidney Foundation – Board of Directors, Trustee.

Nicole M. Lodise. Faculty Affairs Workgroup Chair of the American Association of Colleges of Pharmacy (AACP) Council of Faculties - Curricular Adoption and Integration of the Pharmacists’ Patient Care Process.

Thomas Lodise. Chair, ARLG PK/PD Special Emphasis Panel of Antibiotic Resistance Leadership Group (ARLG).

Thomas Lodise. Vancomycin consensus guideline committee member of American Society of Health-System Pharmacists, Infectious Disease Society of America, Society of Infectious Disease Pharmacists, and the Pediatric Infectious Disease Society.

Thomas Lodise. Editorial Board Member of Antimicrobial Agents and Chemotherapy.

Thomas Lodise. Editorial Board Member of Pharmacotherapy.

Thomas Lodise. Editorial Board of Diagnostic Microbiology and Infectious Diseases.

Darius L. Mason. Chair-Elect of the APhA Academy of Pharmaceutical Research and Science’s Clinical Sciences Section.

Amy Barton Pai. Chair of the Pharmacy Work Group for the NIH-National Kidney Disease Education Program (NKDEP).

D E PA R T M E N T O F P H A R M A C E U T I C A L S C I E N C E S – ALBANY CAMPUS PUBLICATIONS P E E R R E V I E W ED A RTI C L E S Hassan El-Fawal Al-sofiani M, Aljammah A, Hasanato A, Racz M,

28 AC PHS

Mason D, El-Fawal HAN, Mousa SA. Effect of vitamin D supplementation on glucose control and inflammatory response in type 2 diabetes: Double blind, randomized clinical

PR ESID E N T ’S RE PORT

trial. International Journal of Endocrinology Metabolism, Jan 2015, 13(1):e22604, doi: 10.5812/ijem.22604.

Yasin BR, El-Fawal HAN, Mousa SA. Date (phoenix

dactylifera) polyphenolics and other bioactive compounds: A traditional Islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond.

International Journal of Molecular Sciences, 2015, 17;16(12):30075-90. doi: 10.3390/ijms161226210.

Carlos Feleder Johnson A, Neumann PH,

Peng J, James J, Russo V, MacDonald H, Gertzberg N, Feleder C.

nucleus accumbens of conscious rats. Neuropeptides (In Press).

The intracerebroventricular injection of rimonabant inhibits systemic lipopolysaccharide-induced lung inflammation. Journal of Neuroimmunology, Sep 15, 2015; 286:16-24.

Göktalay G, Millington WR. Hypovolemic hemorrhage induces Fos expression in the rat hypothalamus: Evidence for involvement of the lateral hypothalamus in the decompensatory phase of hemorrhage. Neuroscience (In Press).

Millington WR, Yilmaz MS, Feleder C. The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray.

Clinical and Experimental Pharmacology and Physiology (Submitted: In Revision).

Feleder C, Sertac Yilmaz MS, Peng J, Göktalay G, Millington WR. The OVLT initiates the fall in arterial pressure evoked by high dose lipopolysaccharide: Evidence that dichotomous, dose-related mechanisms mediate endotoxic hypotension. Journal of Neuroimmunology, Aug 2015, 285:94-100.

William Millington Feleder C, Yilmaz MS, Peng J, Göktalay G, Millington WR. The OVLT initiates the fall in arterial pressure evoked by high dose lipopolysaccharide: Evidence that dichotomous, dose-related mechanisms mediate endotoxic hypotension. Journal of Neuroimmunology, Aug 2015, 285:94-100.

Millington WR, Yilmaz MS, Feleder C. The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray. Clinical and Experimental Pharmacology and Physiology (Submitted: In Revision).

Basaran NF, Buyukuysal LR, Yilmaz, SM Aydin S, Cavun S, Millington WR. The effect of Gly-Gln [ß-endorphine30-31] on morphine-evoked serotonin and GABA efflux in the

Musteata FM, Sandoval M, Ruiz JM, Harrison K, McKenna D, Millington W. Evaluation of in vivo solid phase microextraction for minimally invasive analysis of nonvolatile phytochemicals in Amazonian plants.

Analytica Chimica Acta (In Review).

Marcel Mustata LaPorte B, Musteata FM. Fluidic device for generating pharmacokinetic profiles matching preset parameters. Journal of Pharmaceutical Innovation, 10(3), 222-232, 2015.

Donabella P, Rogers N, Levin R, Musteata FM. Development of supported liquid phase microextraction probes for in vivo pharmacokinetic studies.

Bioanalysis, Vol. 7(6), p.

661-670, DOI 10.4155/ bio.15.7, 2015.

Alsaqr A, Rasoully M, and Musteata FM. Investigating transdermal delivery of vitamin D3. AAPS PharmSciTech, 16(4), DOI 10.1208/ s12249-015-0291-3, 2015.

Mason D, Donabella P, Nnani D, Musteata FM. Normalized vitamin D metabolite concentrations are better correlated to pharmacological effects than measured concentrations. Future Science OA, FSO83 doi: 10.4155/ FSO.15.83, 2015.

Musteata FM, Sandoval M, Ruiz JM, Harrison K, McKenna D, Millington WR. Evaluation of in vivo solid phase microextraction for

minimally invasive analysis of nonvolatile phytochemicals in Amazonian plants.

Analytica Chimica Acta (In Review) HaiAn Zheng Zheng HA, Truong J, Carroll F, Pai MP. Do formulation differences between reference listed drug and generic products of piperacillin-tazobactam impact reconstitution?

Antimicrobial Agents and Chemotherapy, 59 (3) 17671769, 2015.

BOOK CHAPTER S Hassan El-Fawal El-Fawal, HAN. “Court Systems” in Encyclopedia of Forensic and Legal Medicine. Payne-James J, Byard R, Corey T, Henderson C, eds., 2nd Edition, Volume 2, pp. 662–672, Elsevier Publishing, London, UK, 2016.

El-Fawal, HAN. “Judicial Punishment” in Encyclopedia of Forensic and Legal Medicine. Payne-James J, Byard R, Corey T, Henderson C, eds., 2nd Edition, Volume 3, pp. 282–290, Elsevier Publishing, London, UK, 2016.

El-Fawal HAN, Rembisz P, Alobaidi R, Mousa, SA. “Chemotherapy-mediated pain and peripheral neuropathy: Impact of oxidative stress and inflammation” in Oxidative Damage and Antioxidant Imbalance: The Science of Biology in Health and Disease. Armstrong F, Stratton RD, eds., pp: 367388, John Wiley & Sons, Inc., 2016.

El-Fawal, HAN. “The Tree and the Forest: A Need for Dialogue and a Collaborative Approach in the Safety of Nanomedicines” in Handbook of Clinical Nanomedicine Volume II: Law, Business, Regulation, Safety and Risk. Bawa R (Editor), Audette GF and Reese BE (Assistant Editors), Pan Stanford Publishing, Singapore, 2016.

HaiAn Zheng Wu L, Smith H, Zheng HA, Yu L. Drug Product Approval in the United States and International Harmonization, Developing Oral Solid Dosage Forms.

Academic Press, in press (book chapter co-author).

Zheng, HA. Intravenous Infusion, Applied Biopharmaceutics and Pharmacokinetics, 7th Edition. Leon Shargel and Andrew Yu, eds., McGraw-Hill, September 4, 2015 (chapter editor).

CONFERENCE PRESENTATIONS Richard Dearborn, Jr. Ainsworth M, Voigt JM, Dearborn Jr. RE. Hedgehog-dependent regulation of the VDUP1 tumor suppressor in Drosophila: Developmental and promoter analyses. AAPS Conference, Farmington, CT, April 16, 2015 (abstract).

Hassan El-Fawal El-Fawal HAN. Neurotoxic and autoimmune potential of nanoparticles: Aggravation to amelioration. First International Nanomedicine Symposium and Workshop, ACPHS, August 3-7, 2015.

Cichewicz A, Mason D, Hudgens E, Gallagher JE, El-Fawal HAN. Association of neuroantibodies (NAB) with glutathione-S-transferase (GST) isozyme polymorphisms (SNP) in African-American children with metal exposures. Society of Toxicology Annual Meeting, San Diego, CA, 2015.

Dougherty K, Cichewicz A, Hudgens E, Gallagher JE, El-Fawal HAN. Neuroantibodies (NAB) in African-American (AA) children with metal exposures associate with cytokine and human leukocyte antigen (HLA) polymorphisms (SNP).

Society of Toxicology Annual Meeting, San Diego, CA, 2015.

Sardar J, Mason D, El-Fawal HAN. Association of autoantibodies to nervous system (NS) proteins (NAb) with demographics in hemodialysis (HD) patients.

American Association of Pharmaceutical Sciences (AAPS) Regional Meeting, Storrs, CT, 2015.

Monaco-Brown M, Price D, Horgan M, El-Fawal HAN. Translational utility of neuroantibody (NAb) biomarkers in hypoxic-ischemic encephalopathy (HIE).

Eastern Society for Pediatric Research, Philadelphia, PA, 2015.

Monaco-Brown M, Price D, Horgan M, El-Fawal HAN. Translational utility of neuroantibody (NAb) biomarkers in hypoxic-ischemic encephalopathy (HIE).

Pediatric Academic Societies Annual Conference, San Diego, CA, 2015.

Carlos Felder Russo V, Peng J, MacDonald H, Neumann P, Gertzberg N, Johnson A, Feleder C (presenter).

Brain endocannabinoids mediate lung inflammation during septic shock. International Brain Research Organization 9th World Congress, Rio de Janeiro, Brazil, 2015.

Feleder C. Brain inflammation and psychiatric disorders: Depression and anxiety. Favaloro University, School of Medicine, Buenos Aires, Argentina, August 2015.

Feleder C. Brain endocannabinoids initiates bacterial hypotension and lung inflammation during septic shock. Favaloro University, School of Medicine, Buenos Aires, Argentina, August 2015.

Feleder C. Brain endocannabinoids initiate bacterial hypotension and lung inflammation during septic shock. University Barcelo, School of Medicine, Buenos

AC P H S P RE SID E N T’ S RE PO RT 29

Aires Argentina, August 2015.

Marcel Mustata LaPorte B, Musteata FM. Desktop RAT for generating in vitro pharmacokinetic profiles. Pittcon 2015, New Orleans, LA, March 2015 (oral presentation).

LaPorte B, Musteata FM. 4D-Printed Pharmacokinetic Profiles in Teaching and Research.

AAPS-NERDG, Farmington, CT, April 2015 (poster presentation).

Drug Products – Quality for Safety. China-America Herbal Safety Symposium, Shanghai, JiaoTong University Affiliated Tongren Hospital, October 5, 2015 (invited talk).

HaiAn Zheng Zheng HA. Regulatory Science and Botanical

Cai W, Zheng HA, DiLorenzo J, Briceland LL, Hou A. A China-US exchange

program for clinical pharmacy experiential education: A 6-Year Report.

AACP Annual Meeting, National Harbor, MD, July 11-14, 2015.

Zheng, HA. Regulatory science for botanicals and biologicals – Something old and something new.

Fudan University School of Pharmacy, June 25, 2015 (invited talk).

Cha W, Park K, Zheng HA. Exploring the binding interface between human leptin and leptin receptor. AAPS Northeast Regional Annual Meeting, Hartford, CT, April, 16, 2015.

D E PA R T M E N T O F P H A R M A C E U T I C A L S C I E N C E S – VERMONT CAMPUS PUBLICATIONS P E E R R E V I E W ED A RTI C L E S Stefan Balaz Balaz S. Response to “Comment on ‘Structural Determinants of Drug Partitioning in Surrogates of Phosphatidylcholine Bilayer Strata.’”

Molecular Pharmaceutics 2015, 12, 1330–1334.

Tamer Fandy Fandy TE, Abdullah I, Khayat M, Colby D, Hassan H. In vitro characterization of transport and metabolism of the alkaloids; vincamine, vinpocetine and eburnamonine. Cancer Chemotherapy & Pharmacology 2016, 77, 259-267 (online Dec 2015).

Hamed AA, Wu X, Erickson R, Fandy TE. Twitter K-H networks in action: Advancing biomedical literature for drug search. Journal of Biomedical Informatics 2015, 56, 157-168.

Hassan H, Carlson S, Abdallah I, Buttolph T, Glass KC, Fandy TE. Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells. Pharmaceutical Research 2015, 32, 863-875.

Karen Glass Kim S, Natesan S, Cornilescu G, Carlson S, Tonelli M, McClurg UL, Binda O, Robson CN, Markley JL, Balaz S, Glass KC. Mechanism of Histone H3K4me3

30 AC PHS

recognition by the plant homeodomain of inhibitor of Growth 3. Journal of Biological Chemistry (in revision).

Yana Cen Patel J, Huynh MT, Sowers ML, Theruvathu JA, Zhang K, Sowers LC, Cen Y. Synthesis and characterization of pyrimidine 2’-deoxynucleoside monophosphates as biomarkers of DNA damage and enzymatic modification, Analytical Biochemistry (accepted).

B O O K C HAP T E RS Tamer Fandy Fandy TE. “Epigenetic modifications induced by curcumin and its congeners” in Curcumin: Clinical Uses, Health Effects and Potential Complications. Edited

by Valeria Martin, Nova Science Publishers, Hauppauge, NY (in press).

CONFERENCE PRESENTATIONS Stefan Balaz STEM Saves Lives and Creates Jobs. Vermont Biosciences Alliance, Burlington, VT, April 13, 2015 (panelist).

Tamer Fandy Fandy TE. Epigenetic modifiers as antitumor agents. Festival of Genomics, Boston, MA, June 22-24, 2015.

Hassan H, Keita JA, Narayan L, Brady S,

PR ESID E N T ’S RE PORT

Frederick R, Carlson S, Glass KC, Buttolph T, Fandy TE. The interactive effects of dimethoxycurcumin and decitabine in leukemia cells. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Abstract T3011, 2015.

Hassan H, Keita JA, Narayan L, Brady S, Frederick R, Carlson S, Glass KC, Buttolph T, Fandy TE. The interactive effects of dimethoxycurcumin and decitabine in leukemia cells.

Annual ACPHS Research Forum, Albany, NY, 2015.

Karen Glass Carr F, Glass KC, and Gray J. Epigenetic Signaling and Breast Cancer. Invited talk for panel session on Environmental Endocrine Disruptors and Their Impact on Weight, Metabolism, and Cancer, The 18th Annual Women’s Health and Breast Cancer Conference, Burlington, VT, Oct 2, 2015.

Glass KC, Lubula MY, Poplawski A, Carlson S, Eckenroth BE, Hu K, Lee W, Peng D, Chruszcz M, Shi X, Markley JL. Molecular basis of histone acetyllysine recognition by the BRPF1 bromodomain. 5th Annual ACPHS Research Forum, Albany, NY, January 24, 2015.

Carlson S, Lubula MY, Eckenroth BE, Poplawski P, Neuhardt E, Glass KC.

Epigenetic roles of the MOZ histone acetyltransferase complex. Keystone Symposia on Epigenetics and Cancer, Keystone, CO, Jan 26, 2015.

Glass KC, Lubula MY, Poplawski A, Carlson S, Eckenroth BE, Hu K, Lee W, Peng D, Chruszcz M, Shi X, Markley JL. Molecular Basis of Histone Acetyllysine Recognition by the BRPF1 Bromodomain. Keystone Symposia on Epigenetics and Cancer, Keystone, CO, Jan 26, 2015.

Glass KC. Molecular basis of histone recognition by the MOZ HAT complex.

Epigenomics and Novel Therapeutic Targets, Boston, MA, 2015 (invited talk and session chair of Transcriptional Regulation).

Glass KC. Round Table discussion, Vermont Genetics Network Career Day, Burlington, VT, April 15, 2015.

Senthil Natesan Natesan S, Lynch S, Subramaniam R, Mathew I, Wang Z, Balaz S. Fragment-based prediction of drug distribution across the headgroup and core strata of a phospholipid bilayer: Hexadecane-diacetyl phosphatidylcholine as surrogate phases. 250th American Chemical Society National Meeting, Boston, MA, August 16-20, 2015, COMP-280.

Natesan S, Glass KC, Balaz S. Molecular dynamics simulations of ING3-histone peptides: Free energy calculations and analysis of critical interactions. 5th Annual ACPHS Research Forum, Albany, NY, January 24, 2015.

Petrow B, Natesan S, Cen Y, Balaz S. SIRT6 inhibitors: Lead generation through pharmacophore based virtual screening, molecular docking and molecular dynamics simulation. 5th Annual ACPHS Research Forum, Albany, NY, January 24, 2015.

Yana Cen Cen Y, Zhang K, Lin H. Activity-based photoaffinity labeling of sirtuins. 5th Annual ACPHS Research Forum, Albany, NY, January 24, 2015.

Cen Y, Zhang K, Lin H. Development of activity-based chemical probes for sirtuin profiling. Epigenomics and Novel Therapeutic Targets Conference, Boston, MA, May 2015.

SCHOOL OF ARTS AND SCIENCES D E PA R T M E N T O F B A S I C A N D S O C I A L S C I E N C E S PUBLICATIONS Charles Bergeron Siedlik JA, Bergeron C, Cooper MA, Emmons R, Moreau W, Nabhan D, Gallagher P, Vardiman JP. Advanced treatment monitoring for athletes using unsupervised modeling techniques.

Journal of Athletic Training, in press.

Bergeron C, Lebl J, and other open-source creators.

Differential equations: Including linear algebra topics and computer-aided problem-solving. Self-published online at www.differentialequations.net, CC BY-NC-SA 3.0 license, Aug 29, 2015.

Allison M. Burton-Chase Hovick SR, Yamasaki J, Burton-Chase AM, Peterson SK. Patterns of family health history communication among African American older adults. Journal of Health Communication, 2015, 20 (1); 80-87.

Yusuf RA, Rogith D, Hovick SR, Peterson SK, Burton-Chase AM, Fellman BM, Li Y, McKinney C, Bernstam EV, Meric-Bernstam F. Attitudes toward molecular testing for personalized cancer therapy. Cancer, 2015, 121 (2); 248-250.

Burton-Chase AM, Swartz MC, Silvera SAN, Basen-Engquist K, Fletcher FE, Shields PG. Know your value: Negotiation skills development for junior investigators in the academic environment – A report from the American Society of Preventive Oncology’s Junior Members Interest Group. Cancer Epidemiology, Biomarkers & Prevention, 2015, 24 (7); 1144-1148.

Katz LH, Burton-Chase AM, Advani S, Fellman F, Polivka K. Ying Y, Lynch PM, Pande M, Peterson SK. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Clinical Genetics, 2015, Epub ahead of print.

Burton-Chase AM, Kwak J, Hennig K, Haley WE. Elder Caregiving. In Reference Module of Neuroscience and Biobehavioral Psychology.

New York: Elsevier, in press.

proinflammatory cytokines.

Journal of Biological Chemistry, 2015 Dec 7. pii: jbc.

M115.681478. [Epub ahead of print] PMID: 26644475 (* denotes co-senior authors).

Thomas O’Grady O’Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to over-diagnosis in the United States 1981-2011. International Journal of Cancer, Dec 1, 2015, 137(11):2664-73.

Timothy LaRocca LaRocca TJ, Stivison EA, Mal-Sarkar T, Hooven TA, Hod EA, Spitalnik SL, Ratner AJ. CD59 signaling and membrane pores drive Syk-dependent erythrocyte necroptosis. Cell Death and Disease, May 2015, 6: e1773.

Wendy Parker Campo-Engelstein L, Santacrose LB, Master Z, Parker WM. Bad moms and blameless dads: The portrayal of maternal and paternal age and preconception harm in U.S. newspapers. American Journal of Bioethics: Empirical Bioethics, 2016, 7(1): 56-63. DOI:10.1080/2329451 5.2015.1053007.

Meenakshi Malik Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M*, Bakshi CS*. Preclinical testing of a vaccine candidate against tularemia. PLoS One, April 2015, 10(4): e0124326 (* denotes co-senior authors).

Parker WM, Cho S, Muzzy JD, Cardone KE. Multidisciplinary views toward pharmacist-delivered MTM services in dialysis facilities.

Journal of the American Pharmacists Association, 2015, 55 (4): 390-397, doi: 10.1331/JAPhA.2015.14168.

Banik S, Mansour AA, Suresh RV, Wykoff-Clary S, Malik M, McCormick AA, Bakshi CS. Development of a multivalent subunit vaccine against tularemia using Tobacco Mosaic Virus (TMV) based delivery system.

PLoS One, June 2015, 10(6): e0130858.

Campo-Engelstein L, Howland L, Parker WM, Burcher P. Scheduling the stork: Media portrayals of women’s and physicians’ reasons for cesarean delivery on maternal request. Birth, 2015, 42:2:181-188.

Rabadi SM, Sanchez BC, Varanat M, Ma Z, Catlett SV, Melendez JA, Malik M*, Bakshi CS*. Antioxidant defenses of Francisella tularensis modulate macrophage function and production of

Michael Racz Racz MJ, Sedransk J. Inference for identifying outlying health care providers. Journal of Statistical Planning and Inference, 2015, 160, 51-59.

Alyahya R, Sudha T, Racz MJ, Stain SC, Mousa SA.

Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. International Journal of Oncology, 2015, 46, 1225-1231.

Al-Sofiani ME, Jammah A, Racz MJ, Khawaja RA, Hasanto R, El-Fawal HAN, Mousa SA, Mason DL. Effect of vitamin D supplementation on glucose control and inflammatory response in type II diabetes: A double blind, randomized clinical trial. International Journal of Endocrinology and Metabolism, 2015, 13(1), e22604.

Alzahri M, Almomen A, Hasanato R, Racz MJ, Polimeni J, Mousa SA. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease. Saudi Journal of Kidney Diseases and Transplantation, 2015, 26(6):1161-1168.

PRESENTATIONS Charles Bergeron Bergeron C, Kiehl TR. Extracting connectivity patterns from neural spikes. Joint Mathematics Meetings, San Antonio, TX, January 10-13, 2015 (oral presentation).

Bergeron C. A flipped differential equations with no videos. Joint Mathematics Meetings, San Antonio, TX, January 10-13, 2015 (oral presentation).

Stone T, Kiehl TR, Bergeron C. The role of spatial scale in neural tissue interconnectivity. Next Generation Stem Cell Conference, Saratoga Springs, NY, May 6-7, 2015 (poster presentation).

Stone T, Kiehl TR, Bergeron C. The role of spatial scale in neural tissue interconnectivity. Hitting the Accelerator: Health Research Innovation through Data Science Scientific Session, Rochester, NY, May 28, 2015 (poster presentation).

Stone T, Kiehl TR, Bergeron C. The role of spatial scale in neural tissue interconnectivity. New York Academy of Sciences Quantitative Biology: From Molecules to Man, New York, NY, June 18, 2015 (poster presentation).

Stone T, Kiehl TR, Bergeron C. Learning biological function at various spatial scales in electrophysiological big data. New York Academy of Sciences Leveraging Big Data and Predictive Knowledge to Fight Disease, New York, NY, July 28, 2015 (poster presentation).

Allison M. Burton-Chase Advani S, Polivka K, Katz LH, Burton-Chase AM, Fellman F, Ying Y, Lynch PM, Pande M, Peterson SK. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

MD Anderson Cancer Survivorship Research Retreat, Houston, TX, February 2015 (poster presentation).

Advani S, Polivka K, Katz LH, Burton-Chase AM, Fellman F, Ying Y, Lynch PM, Pande M, Peterson SK. Cancer risk perceptions and screening behaviors in family members of colorectal cancer survivors with Lynch-like syndrome.

MD Anderson Cancer Survivorship Research Retreat, Houston, TX, February 2015 (poster presentation).

AC P H S P RE SID E N T’ S RE PO RT 31

Burton-Chase, AM. Creating and managing a work-life balance in the academic environment: Strategies for Junior Investigators. Annual Meeting of the American Society of Preventive Oncology (ASPO), Birmingham, AL, March 2015 (session chair and organizer).

Katz LH, Burton-Chase AM, Advani S, Fellman F, Polivka K, Ying Y, Lynch PM, Pande M, Peterson SK. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynchlike syndrome. Digestive Disease Week (DDW), Washington, DC, May 2015 (oral presentation).

Burton-Chase, AM. Transitions in care and provider satisfaction in Lynch syndrome survivors and previvors. 19th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer, Baltimore, MD, October 2015 (invited oral presentation and panelist).

Martha Hass Mathur S, Thomas S, Hass MA. Synthesis and evaluation of co-drugs derived from methotrexate and ibuprofen. American Association of Pharmaceutical Scientists Annual Meeting, Orlando, FL, October 25-29, 2015 (poster presentation).

Jock M, Mackey S, Thomas S, Hass MA. Stability and penetration of co-drugs derived from tocopherol (TOC)/tocopherylamine (TOCA) and lipoic acid/lipol in porcine skin. American Association of Pharmaceutical Scientists Annual Meeting, Orlando, FL, October 25-29, 2015 (poster presentation).

Mathur S, Thomas S, Hass MA. Synthesis of co-drugs derived from methotrexate and ibuprofen. 15th Annual AAPS Northeast Regional Discussion Group, Farmington, CT, April 16, 2015 (poster presentation).

32 AC PHS

Timothy LaRocca LaRocca, TJ. Mechanisms and significance of necroptosis. ACPHS-Wadsworth Center Mini-Research Symposium, Albany, NY, June 1, 2015 (oral presentation).

LaRocca TJ, Flaherty NF, Ratner AJ. Hyperglycemic conditions prime cells for RIP1-dependent programmed necrosis in a glycolysis-dependent manner. Eastern New York Student Chapter of the American Society for Microbiology (ENYSCASM), Albany, NY, November 4, 2015 (poster presentation).

Meenakshi Malik Malik M. Immunopathogenesis of Francisella tularensis. ACPHS-Wadsworth Center Mini-Research Symposium, Albany, NY, June 1, 2015 (oral presentation).

Russo V, Ma Z, Deragon M, Dotson R, Catlett SV, Malik M. Characterization of oxidative stress regulator OxyR of Francisella tularensis.

Eastern New York Student Chapter of the American Society for Microbiology (ENYSCASM), Albany, NY, November 4, 2015 (poster presentation).

Silver E, Szaro J, Dotson R, Catlett SV, Malik M. Characterization of a Francisella factor required for suppression of innate immunity.

Eastern New York Student Chapter of the American Society for Microbiology (ENYSCASM), Albany, NY, November 4, 2015 (poster presentation).

Ma Z, Russo V, Rabadi SM, Bakshi CS, Malik M. Regulation of Francisella tularensis genes involved in oxidative stress resistance. 115th General Meeting of American Society for Microbiology, New Orleans, LA, May 30 - June 2, 2015 (poster presentation).

Rabadi SM, Ma Z, Suresh RV, Catlett SV, Banik S, Malik M, Bakshi CS. Antioxidant defenses of Francisella tularensis SchuS4 strain.

PR ESID E N T ’S RE PORT

115th General Meeting of American Society for Microbiology, New Orleans, LA, May 30 - June 2, 2015 (poster presentation).

Ketkar H, Ma Z, Rabadi SM, Malik M, Bakshi CS. Characterization of the outer membrane component of the Emr-multidrug efflux pump. 115th General Meeting of American Society for Microbiology, New Orleans, LA, May 30 - June 2, 2015 (poster presentation).

Banik S, Mansour AM, Suresh RV, Malik M, Lee G, McCormick AA, Bakshi CS. Development of a multivalent subunit vaccine against tularemia using Tobacco Mosaic Virus (TMV) based delivery system. 115th General Meeting of American Society for Microbiology, New Orleans, LA, May 30 - June 2, 2015 (poster presentation).

Wendy Parker Kaufman S, Parker WM, Campo-Engelstein L. Why are there so few male contraceptive options? A content analysis of contemporary U.S. newspaper articles. Capital District Feminist Studies Conference, Albany, NY, January 2015 (poster presentation).

Parker WM. Paradoxes to offer: The women’s health movement as a feminist project. Capital District Feminist Studies Conference, Albany, NY, January 2015 (oral presentation).

Parker WM, Burton-Chase AM. Provider satisfaction in colorectal cancer patients: A comparison between Lynch syndrome and sporadic survivors. Academy Health Annual Research Meeting, Minneapolis, MN, June 2015 (poster presentation).

Kaufman S, Parker WM, Campo-Engelstein L. Why are there so few male contraceptive options? A content analysis of contemporary U.S. newspaper articles. Academy Health

Annual Research Meeting, Minneapolis, MN, June 2015 (poster presentation).

Parker WM, Ferreira K, Vernon L, Cardone KE. Medication management services in a dialysis center: Patient and staff perspectives. Academy Health Annual Research Meeting, Minneapolis, MN, June 2015 (poster presentation).

Parker WM, Donato KM, Burton-Chase AM. Preventive screenings and risks for women with Lynch syndrome: Initial results from a case-control study.

Concordium Fall Research Conference, Washington, DC, September 2015 (poster presentation).

Parker WM, Jang SM, Pai AB, Cardone KE. Health literacy and quality in dialysis patients. Concordium Fall Research Conference, Washington, DC, September 2015 (poster presentation).

Parker WM, Donato KM, Burton-Chase AM. Preventive screening and risk for women with Lynch syndrome: Initial results of a case-control study.

19th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC), Baltimore, MD, October 2015 (poster presentation).

Wright D, Polimeni J, Meek P, Chandrasekara R, Parker WM. The impact of high deductible health plans on preventive care use.

New York State Economics Association, Siena College, Albany, NY, October 2015 (oral presentation).

Parker WM, Smith RA. Peer social networks influence on health. New York State Economics Association, Siena College, Albany, NY, October 2015 (oral presentation).

Meek PD, Parker WM, Racz MJ, Cosler LE, Teynor ME. Differentiating oral

mesalamine adherence patterns in ulcerative colitis patients: A group-based trajectory model approach.

Advances in Inflammatory Bowel Diseases: Crohn’s & Colitis Foundation’s Clinical and Research Conference, Orlando, FL, December 2015 (poster presentation).

Michael Racz Racz MJ, Sedransk J. Inference for identifying outlying health care providers. 11th International Conference on Health Policy Statistics, Providence, RI, October 2015 (oral presentation).

Racz MJ. Inference for identifying outlying health care providers. UpStat 2015, Fourth Joint Conference of the Upstate ASA Chapters, Geneseo, NY, April 2015 (oral presentation).

Eric Yager Reid B, Visconti R, Harton JA, Yager EJ. Molecular regulation of host inflammation during influenza A virus.

Immunology 2015, Annual Meeting of the American Association of Immunologists Annual Meeting, New Orleans, LA, May 8-12, 2015 (oral presentation).

GRANTS Wendy Parker Investigators: Grabe D (PI), Parker WM (Co-PI), Daoui R (Co-PI) Project: Disparities in hypertension among women with chronic kidney disease Grantor: John Faunce and Alicia Tracy Roach Fund Amount: $18,252 Term: July 1, 2015 June 30, 2016 Parker WM (PI), Cardone KE (Co-PI), Daoui R (Co-PI). Project: Coping skills and self-management strategies used to increase medication adherence in the CKD population Grantor: John Faunce and Alicia Tracy Roach Fund Amount: $7,955 Term: Sept 1, 2015 – August 31, 2016

D E P A R T M E N T O F H E A LT H S C I E N C E S PUBLICATIONS Binshan Shi Hug K, Anthony L, Eldeiry D, Benson J, Wheeler E, Mousa SA, Shi B. Expression and tissue distribution of microRNA-21 in malignant and benign breast tissues.

Anticancer Research, June 2015; 35(6): 3175-83.

Markus Stein Mishra JP, Cohen D, Zamperone A, Nesic D, Muesch A, Stein M. CagA of helicobacter pylori interacts with and inhibits the serinethreonine kinase PRK2.

Cell Microbiology, Nov 2015; 17(11): 1670-82.

Ebot Tabe Pearson S, Kloos Z, Murray B, Tabe ES, Gupta M, Kwak JH, Karande P, McDonough K, Belfort G. Combined bioinformatic and rational design approach to develop antimicrobial peptides against mycobacterium tuberculosis. Antimicrobribal Agents and Chemotherapy,

CONFERENCE PRESENTATIONS

Feb 2016, AAC.00940-15.

Tabe N, Rahman S, Tabe ES, Doetkott D, Khaitsa ML. Shigatoxin producing Escherichia coli and Salmonella spp burden in cattle feedlot runoff from two cattle feedlot facilities in North Dakota.

Food Protection Trends, Vol 36, No. 1, pp. 33-42.

Jenna Benson Diagnostic Seminar panelist. American Society for Cytopathology’s (ASC) Annual Scientific Conference, Chicago, IL, November 2015.

D E PA R T M E N T O F H U M A N I T I E S A N D C O M M U N I C AT I O N PUBLICATIONS PEER REVIEWED A RTI C L E S Patricia Baia Baia P, Strang A. Pharmacy educator motives to pursue pedagogical knowledge.

American Journal of Pharmaceutical Education, accepted October 2015 (in press).

Strang A, Baia P. An investigation of teaching and learning programs in pharmacy education.

American Journal of Pharmaceutical Education, Ref. AJPE5210R1, accepted June 2015 (in press).

Garrison G, Baia P, Canning J, Strang A. An asynchronous learning approach for the instructional component of a dual-campus pharmacy resident teaching program.

American Journal of Pharmaceutical Education, v79 (2), 2015.

Paul Denvir Denvir P. Saving face during routine lifestyle history taking: How patients report and remediate potentially problematic conduct. Communication & Medicine, accepted April 2015 (in press).

Margaret Carroll Carroll, Margaret Lasch.

Ireland’s Great Famine in Irish-American History: Enshrining a Fateful Memory by Mary C. Kelly (review).

American Catholic Studies 126.1 (2015): 66-68.

RE VI EW ART I C LE S Michael Pittman Pittman M. Review of “The Holy Trinity and the Law of Three: Discovering the Radical Truth at the Heart of Christianity” by Cynthia Bourgeault. Journal for the Academic Study of Religions, 27.3, Feb 2015.

CONFERENCE PRESENTATIONS S C I E NT I FI C P O ST E RS Patricia Baia Baia P. Faculty motivations for life-long learning. 45th Annual Conference of the International Society for Exploring Teaching and Learning, Savannah, GA, October 15-17, 2015.

Barry DeCoster DeCoster B. Medicalization versus demedicalization: The question of resistance.

American Society for Bioethics and Humanities, Houston, TX, October 2015 (poster presentation) I NVI T E D P RE SE NTAT I O NS Patricia Baia Baia P, Strang A. Leverage: How to create an online certificate program using backdoor tactics. Higher Education Pedagogy Conference, Virginia Tech, Blacksburg, VA, February 4-6, 2015.

Kevin Hickey Hickey K. Infectious diasporas: Africa and discourses of global health – bondage or

embrace? 41st Annual African Literature Association Conference – African Futures and Beyond: Visions in Transition, University of Bayreuth, Germany, June 5, 2015.

Elisabeth Vines Vines E. El Anatsui – Global Artist. 40th Annual NYASA Conference, Albany, NY, April 4, 2015.

PODIU M PR ESENTATIONS Barry DeCoster DeCoster B. Rethinking the ethics of expedited partner therapies. American Society for Bioethics and Humanities, Houston, TX, October 2015.

DeCoster B with Lisa Campo-Engelstein. The medicalization of men’s reproduction.

European Society for Philosophy of Medicine and Healthcare. Paper included in special session on “The Biomedical Model and the Medicalization of Healthcare,” Ghent, Belgium, August 2015.

DeCoster B. The Virtues of Uneasy Collaborations.

North American Society for Social Philosophy, July 2015.

DeCoster B. Fishkin’s Bottlenecks: A Reply to Author.

North American Society for Social Philosophy, July 2015.

DeCoster B. The Myth of Demedicalization? Annual Meeting of the Eastern Sociological Society, New York, NY, Feb 26 - Mar 1, 2015.

Paul Denvir Denvir P. Discursive constructions of Eric Garner and NYC police officers in the de Blasio/Bratton press conference. Presented at the 40th Annual Conference of New York Africana Studies Conference, Albany Law School, April 2015.

Michael Pittman Pittman M. Reflections of orality and textualizations in Gurdjieff’s Beelzebub’s Tales to His Grandson.

International Association for the History of Religions Conference, Erfurt, Germany, August 23-29, 2015.

Pittman M. Desire and devotion in Sergei Parajanov’s The Color of Pomegranates.

American Academy of Religion, Eastern International Region Conference, Montreal, CA, May 1-2, 2015.

Pittman M. Responding to the crisis in higher education: A Taoist and contemplative re-visioning of higher education and leadership.

Comparative and International Education Society Conference, Washington, DC, March 8-13, 2015.

Laura Rogers Rogers L. Re (claiming) Lila: Understanding the fragmentary narratives of incarcerated girls in the early 20th century. Conference on College Composition and Communication, Tampa, FL, March 18-21, 2015.

Rogers L. Into the Archives.

Narrative Truth: The Risks and Rewards of Prison Research, Writing and Teaching Workshop, Conference on College Composition and Communication, Tampa, FL, March 18-21, 2015.

Rogers L with Santicola T, Callaghan C, Kaley A, Yehia, A. We Don’t Talk About That Here: Or do we? (Dis) embodiment in the Science Based Writing Center. Northeast Writing Centers Association Conference, Centenary College, Hackettstown, NJ, April 18-19 2015.

Rogers L with Jacobi T. Deviance or defiance: Counternarrating stories of incarcerated girls. 10th Annual Feminisms and Rhetorics Conference, Arizona State University, Tempe, AZ, October 28-31, 2015.

PROFESSIONAL APPOINTMENTS Paul Denvir Denvir P. Vice-chair, Language and Social Interaction Division of National Communication Association. Served as Division Planner for the 101st Annual Meetings, Las Vegas, NV, November 2015.

Kevin Hickey Elected Vice President of The New York African Studies Association (2-year term) in April 2015.

AC P H S P RE SID E N T’ S RE P O RT 33

PHARMACEUTICAL RESEARCH INSTITUTE PUBLICATIONS P E E R R E V I E W ED A RTI C L E S Dhruba J. Bharali *Hariri W, Sudha T, Bharali DJ, Cui H, Mousa SA (2015).

Nano-targeted delivery of toremifene, an estrogen receptor-alpha blocker in prostate cancer. Pharmaceutical Research 32:27642774.

Safer AM, Hanafy NA, Bharali DJ, Cui H, Mousa SA (2015). Effect of green tea extract encapsulated into chitosan nanoparticles on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model.

Journal of Nanoscience and Nanotechnology 15:6452-6459.

Shirode AB, Bharali DJ, Nallanthighal S, Coon JK, Mousa SA, Reliene R (2015). Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention.

International Journal of Nanomedicine 10:475-484.

Vandhana M-Chari *Alshaiban A, Muralidharan-Chari V, Nepo A, Mousa SA (2015). Modulation of sickle red blood cell adhesion and its associated changes in biomarkers by sulfated non-anticoagulant heparin derivative. Clinical and Applied Thrombosis/ Hemostasis 22:230-238.

Paul J. Davis Davis PJ, Glinsky GV, Lin HY, Leith JT, Hercbergs A, Tang HY, Ashur-Fabian O, Incerpi S, Mousa SA (2015). Cancer cell gene expression modulated from plasma membrane integrin alphavbeta3

34  AC PHS

by thyroid hormone and nanoparticulate tetrac.

Frontiers in Endocrinology (Lausanne) 5:240.

Davis PJ, Incerpi S, Lin HY, Tang HY, Sudha T, Mousa SA (2015). Thyroid hormone and P-glycoprotein in tumor cells. BioMed Research International 2015:168427.

Hercbergs A, Johnson RE, Ashur-Fabian O, Garfield DH, Davis PJ (2015). Medically induced euthyroid hypothyroxinemia may extend survival in compassionate need cancer patients: An observational study. The Oncologist 20:72-76.

Lin HY, Glinsky GV, Mousa SA, Davis PJ (2015). Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget 6:14735-14743.

Shaker A. Mousa *Alshaiban A, Muralidharan-Chari V, Nepo A, Mousa SA (2015). Modulation of sickle red blood cell adhesion and its associated changes in biomarkers by sulfated non-anticoagulant heparin derivative. Clinical and Applied Thrombosis/ Hemostasis 22:230-238. *Al-Sofiani ME, Jammah A, Racz M, Khawaja RA, Hasanato R, El-Fawal HA, Mousa SA, Mason DL (2015). Effect of Vitamin D supplementation on glucose control and inflammatory response in type ii diabetes: A double blind, randomized clinical trial.

International Journal of Endocrinology and Metabolism 13:e22604. *Alyahya R, Sudha T, Racz M, Stain SC, Mousa SA (2015). Anti-metastasis

PR ESID E N T ’S RE PORT

efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. International Journal of Oncology 46:1225-1231.

Darwish NHE, Mousa SA (2015). Intrinsic targeting strategies against acute myeloid leukemic stem cells.

Integrative Cancer Science and Therapeutics 2. DOI: 10.15761/ICST.1000135.

*Alzahri MS, Mousa SA, Almomen AM, Hasanato RM, Polimeni JM, Racz MJ (2015). Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease.

Saudi Journal of Kidney Diseases and Transplantation 26:1161-1168.

Davis PJ, Glinsky GV, Lin HY, Leith JT, Hercbergs A, Tang HY, Ashur-Fabian O, Incerpi S, Mousa SA (2015). Cancer cell gene expression modulated from plasma membrane integrin alphavbeta3 by thyroid hormone and nanoparticulate tetrac. Frontiers in Endocrinology (Lausanne) 5:240.

Bani-Jaber A, Cui H, Elsaid A, Yalcin M, Sudha T, Mousa SA (2015). Pegylated solid lipid nanoparticles reconstituted from high-density lipoprotein components for hepatic targeting. Science Letters Journal 4.

Davis PJ, Incerpi S, Lin HY, Tang HY, Sudha T, Mousa SA (2015). Thyroid hormone and P-glycoprotein in tumor cells. BioMed Research International 2015:168427.

*Belousova V, Abd-Rabou AA, Mousa SA (2015).

Recent advances and future directions in the management of hepatitis C infections. Pharmacology & Therapeutics 145:92-102.

Block RC, Abdolahi A, Tu X, Georas SN, Brenna JT, Phipps RP, Lawrence P, Mousa SA (2015). The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA. Prostaglandins Leukotrienes and Essential Fatty Acids 96:17-24.

Darwish NHE, Mousa SA (2015). Extrinsic targeting strategies against acute myeloid leukemic stem cells.

Integrative Cancer Science and Therapeutics 2 DOI 10.15761/ICST.1000134.

Davis PJ, Sudha T, Lin HY, Mousa SA (2015). Thyroid hormone, hormone analogs, and angiogenesis.

Comprehensive Physiology 6:353-362. *Ebright J, Mousa SA (2015).

Oral anticoagulants and status of antidotes for the reversal of bleeding risk. Clinical and Applied Thrombosis-Hemostasis 21:105-114.

in malignant and benign breast tissues. Anticancer Research 35:3175-3183.

Lin HY, Glinsky GV, Mousa SA, Davis PJ (2015). Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget 6:14735-14743.

Obradovic M, Zafirovic S, Jovanovic A, Milovanovic ES, Mousa SA, Labudovic-Borovic M, Isenovic ER (2015). Effects of 17 beta-estradiol on cardiac Na+/K+-ATPase in high fat diet fed rats. Molecular and Cellular Endocrinology 416:46-56.

Rajabi M, Hossaini Z, Khalilzadeh MA, Datta S, Halder M, Mousa SA (2015).

Synthesis of a new class of furo 3, 2-c coumarins and its anticancer activity. Journal of Photochemistry and Photobiology B: Biology 148:66-72.

Safer AM, Afzal M, Hanafy N, Mousa SA (2015).

Green tea extract therapy diminishes hepatic fibrosis mediated by dual exposure to carbon tetrachloride and ethanol: A histopathological study. Experimental and Therapeutic Medicine 9:787-794.

*Hariri W, Sudha T, Bharali DJ, Cui H, Mousa SA (2015).

Nano-targeted delivery of toremifene, an estrogen receptor-alpha blocker in prostate cancer. Pharmaceutical Research 32:27642774.

Safer AM, Sen A, Hanafy NA, Mousa SA (2015).

Quantification of the healing effect in hepatic fibrosis induced by chitosan nano-encapsulated green tea in rat model. Journal of Nanoscience and Nanotechnology 15:9918-9924.

Hug KA, Anthony L, Eldeiry D, Benson J, Wheeler E, Mousa SA, Shi B (2015).

Expression and tissue distribution of microrna-21

Safer AM, Hanafy NA, Bharali DJ, Cui H, Mousa SA (2015). Effect of green tea extract encapsulated into chitosan nanoparticles

on hepatic fibrosis collagen fibers assessed by atomic force microscopy in rat hepatic fibrosis model. Journal of Nanoscience and Nanotechnology 15:6452-6459.

Shirode AB, Bharali DJ, Nallanthighal S, Coon JK, Mousa SA, Reliene R (2015). Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention.

International Journal of Nanomedicine 10:475-484.

Srinivasan M, Rajabi M, Mousa SA (2015). Multifunctional nanomaterials and their applications in drug delivery and cancer therapy. Nanomaterials 5:1690-1703.

Stanimirovic J, Obradovic M, Zafirovic S, Resanovic I, Bogdanovic N, Gluvic Z, Mousa SA, Isenovic ER (2015). Effects of altered hepatic lipid metabolism on regulation of hepatic iNOS. Clinical Lipidology 10:167-175.

Tarazi FI, Sahli ZT, *Pleskow J, Mousa SA (2015). Asperger’s syndrome: Diagnosis,

comorbidity and therapy.

Expert Review of Neurotherapeutics 15:281-293.

Trpkovic A, Resanovic I, Stanimirovic J, Radak D, Mousa SA, Cenic-Milosevic D, Jevremovic D, Isenovic ER (2015). Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Critical Reviews in Clinical Laboratory Sciences 52:70-85. *Vogel R, Hussein EA, Mousa SA (2015). Stem cells in the management of heart failure: What have we learned from clinical trials?

Expert Review of Cardiovascular Therapy 13:75-83. *Yasin BR, El-Fawal HA, Mousa SA (2015). Date (phoenix dactylifera) polyphenolics and other bioactive compounds: A traditional Islamic remedy’s potential in prevention of cell damage, cancer therapeutics and beyond. International Journal of Molecular Sciences 16:30075-30090.

B O O K C HAP T ERS El-Fawal HAN, *Rembisz R, *Alobaidi R, Mousa SA

(2016). “Chemotherapy-mediated pain and peripheral neuropathy: Impact of oxidative stress and inflammation” in Oxidative Stress and Antioxidant Protection. John Wiley & Sons, Inc, pp 367-388.

DOI:10.1002/9781118832431. ch24. * Denotes ACPHS Pharm.D. or M.S. students

CONFERENCE PRESENTATIONS Shaker A. Mousa Keynote Speaker. 4th Hematology Congress XIII, Abu Dhabi, UE, Feb 2-6, 2015.

SUNY/Turkish Council Conference “Innovative Cancer Research - Translating Clinical and Population Research,” Albany, NY, April 15-17, 2015.

Keynote Speaker. International Congress on Blood Disorders - Thalassemia / Sickle cell Diseases, May 4-8, 2015.

Keynote Speaker. Angiogenesis Symposium, Meet-

ing of the Physiological Society, Cardiff, Wales, July 5-8, 2015.

Best of Sciences presentation. American Heart Association Meeting, Orlando, FL, November 7-11, 2015.

EXTRAMURAL GRANTS Shaker A. Mousa Project: Nanotetrac Synthesis Process Chemistry for Production of Sterile Product: Evaluation of Physical/Chemical and Biological Profiles (Task 4) Grantor: Nano Pharmaceuticals LLC Total award: $87,600 Start Date: 1/1/15 Project: Measurements of Diaminotetrac and Tetrac in Plasma Using LC/MS/MS (Task 4 Amendment) Grantor: Nano Pharmaceuticals LLC Total award: $22,000 Start Date: 2/18/15 Project: Scale-Up of Nano Diaminotetrac for its Safety Assessment in Male and Female Mice after Daily Exposure at Different Doses

for 15 Days (Task 5).

Grantor: Nano Pharmaceuticals LLC Total award: $52,000 Start Date: 2/12/15 Project: Optimization of Nano-diamino-tetrac formulation for Scale up and assessment of Bioequivalence: Selection of Stabilizer (Task 3, Amendment A).

Grantor: NanoPharmaceuticals LLC Total award: $31,872 Start Date: 6/12/15 Project: Analytical Method Development for Nano-diamino-tetrac (N-DAT) Pharmacokinetic Studies (Task 6).

Grantor: NanoPharmaceuticals LLC Total award: $63,360 Start Date: 6/24/15 Project: Optimization of Nano-diamino-tetrac formulation (Highest Possible DAT % loading) for Scale up and assessment of Bioequivalence: Selection of Stabilizer (Task 7) Grantor: Nano Pharmaceuticals LLC Total award: $74,958 Start Date: 10/28/15

INSTRUCTIONAL DESIGN SERVICES PUBLICATIONS Tammy Garren Zarbock S, Garren T. Graduated quizzes in a diabetes mellitus therapeutics module and impact on student learning and satisfaction.

Currents in Pharmacy Teaching and Learning, 8, 39-46. DOI: http:// dx.doi.org/10.1016/j. cptl.2015.09.019.

Garren T, Skylstad K. Scaffolded online learning modules for milliequivalency and milliosmolarity calculations. Currents in Pharmacy Teaching and Learning (in press).

CONFERENCE PRESENTATIONS Tammy Garren Garren T, Skylstad K. Differentiated and flexible learning environment for calculations in a pharmacy skills lab.

Northeastern Educational Research Association Annual Conference, Trumbull, CT, October 2015 (poster session).

Marie Michaud-Sacks Koo, CL, Farris C, Feinberg D, Michaud-Sacks M, Camiel LD, Goldman J. Flipped classroom in pharmacy education.

American Association of Colleges of Pharmacy’s Technology in Pharmacy Education and Learning Special Interest Group (TiPEL SIG) webinar series, moderated by Demps, E, 2015.

Judy Teng Teng J. Instructional design for everyone. NorthEast Regional Computing Program (NERCOMP), Affiliation of EDUCAUSE, Norwood, MA, November 2015 (invited panelist).

AC P H S P RE SID E N T’ S RE PO RT 35

FINANCIAL REPORT J U LY 1 , 2 0 1 4 – J U N E 3 0 , 2 0 1 5

STATEMENT OF FINANCIAL POSITION

TOTA L A S S ETS

TOTA L LIA B ILITIES

NET A SSETS

RE V E N UES

EXPENSES

ASSE TS Cash and cash equivalents____________________ 24,596,188 Investments_______________________________ 45,022,987 Other assets_________________________________ 1,737,651 Accounts receivable - Students___________________ 450,230 Receivables-Government entities_________________ 405,697 Pledges receivable___________________________ 1,686,661 Student loan receivable_______________________ 2,510,358 Assets held in charitable remainder annuity trust_____ 164,780 Other receivables_____________________________ 268,270 Agency funds________________________________ 331,563 Deposits with Bond Trustees_______________________ 10,251 Property, plant & equipment-Net_______________ 48,846,892 TOTAL ASSE TS_______________________ $ 126,03 1 ,5 2 8 LIABILITIE S Accounts payable and accrued liabilities_________ $2,206,161 Deferred income and deposits_________________ $7,243,354 U.S. government grants refundable______________ $2,313,459 Bonds payable____________________________ $24,846,017 Expected post retirement benefit obligation_______ $1,791,640 Other liabilities______________________________ $1,102,126 Deposits held in custody for others_______________ $331,563 TOTAL LIABILITIE S____________________ $ 39,8 3 4 ,3 2 0 NE T ASSE TS Unrestricted net assets______________________$73,578,075 Temporarily restricted assets_________________ $4,396,059 Permanently restricted assets_________________ $8,223,074 TOTAL NET ASSETS____________________ $ 86 ,1 9 7,2 08 TOTAL LIABILITIES AND NET ASSETS____ $ 126,03 1 ,5 2 8

STATEMENT OF ACTIVITIES

RE V E N U E S Student tuition and fees__________________________ 74.15% Auxiliary enterprises_____________________________9.20% Gifts and pledges_______________________________4.99% Government contracts and grants___________________ 4.77% Other sources__________________________________ 3.53% Investment income______________________________3.22% Postgraduate education__________________________ 0.14% TOTA L_______________________________________ 100%

36 AC PHS

PR ESID E N T ’S RE PORT

E X PE NSE S Instruction/Student services_______________________ 43.77% Physical plant_________________________________ 26.51% General administration___________________________18.12% Research______________________________________6.29% Institutional advancement_________________________3.03% Student financial aid_____________________________ 1.67% Postgraduate education__________________________ 0.61% TOTAL_______________________________________ 1 00%

BOA RD OF T RU S TEES OF F I C E RS Herbert Chorbajian, Chairman Marion Morton, ’84, Vice Chair Christopher D. Mitiguy, Treasurer Kandyce J. Daley, ’74, Secretary TERM TRUSTEES Stephen Ainlay Matthew Bette Raymond Bleser Jr., ’81 Walter S. Borisenok Leigh Briscoe-Dwyer, ’87 Thomas D’Ambra Paul DerOhannesian II Chris Di Lascia, ’83 Michael Duteau, ’92 Geno J. Germano, ’83 Rocco Giruzzi, ’58 Susan Learned, ’91 James Notaro, ’84 Scott Terrillion, ’85 Pamela Williamson

PUB L ISHED M AY 20 16 EDITOR Gil Chorbajian PHOTOGRAPHY Brad Paris Kris Qua Shayne Ross DESIGN 2Communiqué

AC P H S P RE SID E N T’ S RE PO RT 3

ALBANY COLLEGE OF PHARMACY A N D H E A LT H S C I E N C E S 106 NEW SCOTLAND AVENUE ALBANY, NY 12208 WWW.ACPHS.EDU